Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261210	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 46.5;Astrocytes: 167.8;Early spermatids: 52.9;Hepatocytes: 53.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"basophil: 7.0;neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3;ASC TERT1: 16.1;Hep G2: 42.6;hTERT-RPE1: 14.0;RH-30: 19.1;SK-BR-3: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	22.7	14.5	5.2	1.5	5.1	0.1	7.3	5.2	5.3	8.3	9.3	2.2	0.7	9.1	12.1	1.5	8.0	8.1	6.8	4.7	4.9	25.9	40.0	6.4	1.5	5.5	6.4	16.7	2.0	13.7	4.4	4.0	5.2	5.7	1.0	4.8	12.1	5.5	3.5	1.7	1.5	6.3	4.9	2.1	1.4	2.3	6.5	1.1	8.8	5.7	1.1	2.8	5.0	5.5	0.0	0.2	3.4	0.0	14.3	16.1	0.1	2.2	11.0	1.7	1.9	0.4	0.1	0.0	0.0	5.0	5.2	0.1	0.0	0.0	1.0	0.0	2.2	0.0	0.0	42.6	4.8	0.1	0.0	10.8	0.0	0.5	0.0	14.0	0.4	0.0	0.0	0.0	7.8	1.0	0.1	0.2	4.8	0.0	0.0	0.0	19.1	2.7	0.1	0.1	3.1	0.0	0.0	18.0	0.1	7.1	7.9	0.5	0.0	2.8	2.7	0.2	1.2	0.1	0.1	0.1	3.5	0.0	3.4	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	5.2	5.1	5.2	5.3	4.7	4.9	5.5	6.4	5.2	4.9	6.5	5.5	1.3	22.4	46.5	167.8	0.2	0.9	9.5	0.0	2.2	37.8	5.6	3.0	21.8	14.3	3.2	12.9	4.2	1.5	0.1	0.1	5.9	6.4	52.9	3.9	14.8	1.5	0.0	0.0	1.5	2.9	0.8	12.1	0.0	2.7	0.0	8.8	1.8	53.6	0.7	28.6	1.6	0.1	0.0	3.2	0.6	9.4	23.9	0.8	0.0	35.6	0.1	16.4	0.0	16.6	0.7	0.1	0.1	23.7	0.0	3.0	1.1	31.7	3.7	5.3	6.6	18.6	9.9	4.6	0.6	0.4	0.1	0.5	0.6	13.2	1.2	3.7
ATRNL1	"ALP, FLJ45344, KIAA0534"	ENSG00000107518	"Attractin like 1"	Q5VV63	10	115093365-115948999	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 91.1"	"Group enriched"	"Detected in many"	13	"Excitatory neurons: 2134.6;Inhibitory neurons: 1473.4;Oligodendrocyte precursor cells: 1456.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 91.1;white matter: 58.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.4;RH-30: 18.4;U-266/70: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038070			Approved	Nucleoplasm,Mitochondria		NA	NA		160000000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"		"HPA038070: AB_10697237"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.08e-3)"	0.7	10.7	3.8	0.2	9.5	0.0	1.0	0.0	91.1	0.9	0.0	2.4	0.3	6.2	0.3	0.5	1.0	0.2	1.8	18.3	0.0	2.8	1.5	0.1	0.4	0.0	0.2	9.7	1.3	2.1	5.8	1.9	1.0	3.1	0.2	6.3	1.0	3.8	2.8	0.2	0.8	5.8	0.0	0.3	0.4	12.6	0.0	0.4	1.0	0.0	0.4	0.6	1.0	58.7	0.0	0.6	6.3	21.4	0.0	0.0	0.0	0.1	0.6	3.9	4.6	0.2	0.2	0.0	1.5	0.5	5.1	0.0	1.6	0.0	4.0	0.1	4.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	6.4	0.0	11.3	0.0	5.3	10.4	0.2	9.9	0.0	9.1	0.0	0.1	7.5	18.4	11.4	3.9	0.0	3.6	10.5	0.0	0.1	0.4	4.3	1.8	0.0	0.0	0.0	2.7	0.1	3.3	14.2	0.0	4.6	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.5	0.0	91.1	18.3	0.0	0.0	0.2	1.0	0.0	0.0	58.7	0.0	0.0	0.0	55.8	0.8	0.6	0.1	0.8	0.6	35.4	2.1	0.5	2.5	0.0	0.1	0.0	2.1	0.1	0.2	0.2	0.0	0.7	45.6	0.8	1.5	1.5	0.0	0.0	2134.6	0.4	0.0	5.3	0.0	1.8	0.0	24.9	21.0	0.1	3.0	10.1	1473.4	0.0	0.0	1.9	0.4	47.8	1.5	0.3	0.0	128.4	0.0	4.3	0.0	1456.7	34.2	0.3	0.0	0.7	0.0	0.1	0.0	0.5	0.1	4.7	0.0	2.4	2.6	46.6	11.5	0.0	0.1	0.3	0.1	53.1	0.0	0.1
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15703065-15738313	"CD markers, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 139.8;intestine: 48.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 40.8;Macrophages: 33.3;monocytes: 80.1;Proximal enterocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 257.7;neutrophil: 292.7"	"Group enriched"	"Detected in many"	95	"dendritic cells: 78.9;granulocytes: 292.7;monocytes: 257.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 76.0;TIME: 40.4;U-937: 52.5;WM-115: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	NA	NA		190000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	21.2	2.7	1.9	13.7	2.1	139.8	9.4	2.1	4.7	11.0	1.6	8.3	48.6	6.3	2.9	4.6	7.9	18.2	19.1	2.1	2.0	17.0	8.5	12.7	7.1	1.9	1.4	9.3	3.1	1.7	1.3	13.7	2.2	3.7	9.7	1.0	3.9	4.6	2.7	5.0	29.3	9.7	0.8	18.6	3.2	2.7	3.0	3.9	4.9	6.8	3.5	16.8	7.4	3.3	0.6	10.5	1.2	1.0	28.8	7.0	1.6	21.0	2.1	20.4	22.2	0.3	12.1	0.8	1.9	12.2	0.6	0.3	3.3	0.5	17.2	0.8	0.7	5.6	0.8	0.6	6.7	7.2	15.1	5.7	1.5	12.9	1.0	0.9	3.0	5.0	0.7	0.5	12.5	0.3	2.3	4.3	2.7	0.9	2.2	0.8	1.8	0.5	0.5	0.6	1.4	4.3	0.4	0.7	14.2	1.2	0.5	76.0	40.4	0.6	1.0	7.9	1.1	0.6	0.2	0.7	2.7	52.5	44.8	41.8	257.7	20.8	1.1	97.4	1.7	2.2	0.9	0.8	78.9	0.9	1.1	0.7	292.7	0.4	73.9	26.6	1.0	109.8	1.9	2.1	2.1	4.7	2.1	2.0	1.9	1.4	2.2	0.8	3.0	3.3	5.4	3.2	3.7	1.3	0.3	4.6	0.8	0.1	1.8	0.6	1.2	2.0	1.5	2.8	1.0	1.8	0.0	16.0	5.5	3.7	1.9	4.4	4.4	8.0	9.9	3.8	1.2	2.5	0.7	2.5	24.0	22.5	0.0	16.2	15.9	20.6	6.4	2.1	40.8	0.0	0.7	8.1	0.0	26.3	11.5	1.2	3.1	33.3	14.2	3.7	80.1	0.6	3.1	0.5	3.6	1.1	11.9	2.2	0.4	0.6	79.0	9.6	3.0	0.2	6.6	3.9	15.5	2.5	1.4	1.7	3.0	7.1	1.8	1.4	23.2	3.3
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347754-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 23.7;Leydig cells: 23.3;Peritubular cells: 29.7;Skeletal myocytes: 16.9;Smooth muscle cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"RH-30: 34.4;U-138 MG: 15.1;U-2 OS: 8.3;WM-115: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Centrosome"		"HPA061290: AB_2684468"	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	2.8	0.6	0.9	0.7	0.9	0.1	1.9	1.2	1.3	4.7	0.1	2.5	1.2	3.3	1.1	1.4	2.3	1.8	3.9	0.9	0.8	0.6	0.4	2.4	0.3	0.3	1.3	1.3	0.3	0.2	0.5	0.8	0.2	1.9	1.1	0.2	1.3	1.0	1.9	1.4	2.3	1.8	0.2	0.6	2.0	1.8	2.5	0.1	2.1	2.1	0.3	2.1	2.6	0.8	0.3	0.0	0.5	0.1	0.0	0.0	0.0	3.9	5.3	0.9	3.3	0.1	0.9	0.0	0.1	1.4	0.6	0.2	0.1	0.4	0.2	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	34.4	0.0	0.0	0.2	0.0	0.8	1.0	0.1	0.2	0.1	0.4	0.1	0.2	15.1	8.3	1.5	4.4	0.1	0.0	0.0	0.5	0.0	6.8	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.9	0.9	1.2	1.3	0.9	0.8	0.3	1.3	0.2	0.2	2.5	0.8	2.0	0.0	0.0	0.0	0.0	6.5	0.2	0.2	0.6	0.8	0.3	0.4	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.1	0.0	0.1	1.0	4.2	0.0	0.0	0.6	0.2	0.3	23.7	0.5	0.2	0.0	0.2	1.1	0.0	1.1	0.0	6.2	0.1	0.0	0.0	6.2	0.4	23.3	0.5	5.4	1.0	0.6	0.1	0.0	1.0	0.3	0.1	0.1	29.7	0.0	0.1	0.0	0.0	0.0	0.8	0.0	16.9	22.8	0.1	0.5	0.6	3.8	0.8	0.3	2.1	0.1	0.3
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446167	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.8;Fibroblasts: 32.3;Leydig cells: 22.7;Peritubular cells: 31.6;Skeletal myocytes: 15.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 4.2;ASC TERT1: 2.8;HSkMC: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	238000000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596"	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	7.8	1.4	1.2	1.6	1.2	0.0	4.7	1.2	2.6	23.1	0.0	8.6	1.2	16.5	10.2	6.0	6.3	14.0	7.0	0.8	1.8	5.5	1.2	10.8	1.2	1.1	1.8	20.9	0.8	0.1	1.1	7.2	0.9	9.5	4.2	0.1	2.5	3.2	0.6	3.2	3.8	12.0	0.6	9.7	9.0	1.7	1.8	0.4	3.8	6.6	0.5	10.3	10.3	1.3	0.0	0.0	0.0	0.0	4.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.2	2.6	0.8	1.8	1.1	1.8	0.9	0.6	1.8	1.3	1.2	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.0	15.8	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.1	0.2	6.5	0.5	0.0	0.0	1.0	0.0	0.3	32.3	0.0	0.6	0.0	2.0	0.0	0.0	0.1	1.7	4.4	0.0	0.0	0.0	3.2	0.5	22.7	0.3	5.4	6.5	0.0	0.3	0.0	2.5	0.7	0.0	0.0	31.6	0.2	0.1	0.0	2.8	0.0	1.2	6.6	15.2	9.9	0.0	0.1	0.6	3.0	0.0	0.7	5.7	0.0	0.1
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CHST14	"D4ST-1, D4ST1, HD4ST"	ENSG00000169105	"Carbohydrate sulfotransferase 14"	Q8NCH0	15	40470984-40473158	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.5;Extravillous trophoblasts: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057697, HPA071601"	Enhanced		Approved	"Golgi apparatus"		NA	NA		20000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"		"HPA057697: AB_2683505, HPA071601: AB_2686425"	"unprognostic (5.46e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.25e-2)"	14.2	9.6	6.8	7.7	7.5	3.4	13.7	7.0	6.5	22.0	7.3	11.8	4.5	21.6	8.0	8.7	16.5	11.3	13.8	6.2	7.0	10.1	8.8	13.0	8.5	8.0	7.1	21.1	8.1	11.3	14.4	27.0	7.2	14.6	4.6	1.6	11.0	15.4	5.0	9.1	9.9	12.6	7.5	13.6	9.4	7.9	7.0	8.6	15.8	7.4	7.5	16.1	16.1	7.3	26.2	17.1	26.4	71.6	40.4	31.0	43.0	25.2	47.3	43.5	40.9	21.2	12.8	4.3	37.6	42.7	76.7	43.7	23.7	14.2	20.3	31.5	15.0	13.4	16.9	19.8	22.5	5.7	33.4	38.3	11.6	15.4	11.6	47.8	39.2	15.1	13.6	15.0	32.6	20.1	9.6	29.8	17.0	7.9	20.1	26.2	33.4	7.6	29.5	13.3	19.7	30.2	22.2	24.4	8.4	31.9	35.7	23.9	31.9	73.0	27.1	23.3	25.5	30.3	22.6	12.2	32.8	19.6	53.7	7.6	1.1	2.2	2.2	1.1	0.6	0.3	1.1	1.9	2.0	1.1	0.9	0.8	0.1	3.3	0.6	0.7	0.8	0.7	6.8	7.5	7.0	6.5	6.2	7.0	8.0	7.1	7.2	7.5	7.0	7.3	10.6	12.8	1.1	2.0	5.8	3.4	5.4	4.1	9.1	0.6	5.8	9.7	3.2	7.2	4.6	3.7	0.0	46.5	3.5	0.5	0.0	7.7	1.8	3.2	14.5	10.2	2.4	10.7	0.1	4.9	32.4	19.3	0.0	5.6	4.5	14.9	15.4	3.7	9.3	1.7	0.1	1.4	2.0	5.6	3.3	1.3	17.7	5.6	5.4	2.8	3.4	9.8	6.2	2.0	0.5	5.2	0.3	11.7	1.9	3.6	0.2	1.1	3.0	0.8	6.6	11.8	9.2	7.5	1.3	5.6	2.6	13.5	4.9	3.9	1.9	1.3
CNTFR		ENSG00000122756	"Ciliary neurotrophic factor receptor"	P26992	9	34551432-34590140	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 94.1;skeletal muscle: 129.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Fibroblasts: 22.4;Muller glia cells: 83.6;Paneth cells: 30.6"	"Cancer enhanced"	"Detected in many"		"glioma: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 109.3;SH-SY5Y: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025310	Approved					NA	NA		55000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025310: "	"unprognostic (1.39e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.72e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	60.0	10.3	67.2	1.3	91.9	0.0	49.7	81.5	69.0	29.7	16.3	7.6	3.3	2.8	2.6	3.9	13.0	6.3	39.0	54.3	58.5	2.9	12.4	3.8	1.0	57.0	82.8	5.2	2.2	0.2	9.7	5.2	62.2	11.0	2.2	13.9	11.3	7.7	129.7	11.5	8.7	0.7	49.8	30.6	7.0	7.2	94.1	5.1	13.7	35.1	0.4	5.6	17.1	47.4	0.0	0.0	109.3	0.0	13.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	3.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	52.1	0.1	0.1	0.0	1.0	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	91.9	81.5	69.0	54.3	58.5	57.0	82.8	62.2	49.8	94.1	47.4	0.9	0.0	0.0	57.1	0.0	3.6	1.1	0.0	1.2	19.3	11.9	1.5	1.3	8.6	0.0	0.0	6.2	0.9	0.1	6.5	1.9	0.1	4.3	0.1	2.4	0.3	0.0	0.0	4.1	0.0	0.6	22.4	0.0	0.1	0.0	0.0	2.5	1.4	1.4	3.3	9.3	0.5	0.0	0.0	2.7	1.9	9.9	0.1	3.6	2.8	0.0	83.6	0.0	15.1	0.5	0.0	30.6	2.2	0.3	0.2	14.1	0.1	0.0	3.2	0.0	1.2	1.9	5.5	19.8	0.3	2.4	2.3	0.2	0.0	0.5	0.3
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120373573	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 205.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;Endometrial stromal cells: 97.0;Fibroblasts: 235.9;Smooth muscle cells: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 54.4;hTERT-RPE1: 29.7;RH-30: 123.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		3200000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.01e-4)"	69.0	16.2	1.6	42.2	1.9	0.3	58.8	1.5	2.4	205.8	2.9	39.8	7.7	78.2	35.2	50.2	46.2	142.2	45.4	1.5	2.0	32.1	19.5	27.7	12.8	3.4	2.2	83.2	15.7	6.0	4.0	152.7	2.7	43.8	53.9	0.6	13.5	24.9	7.0	13.3	35.3	147.6	3.1	28.4	25.6	5.5	2.4	5.3	43.2	36.1	16.5	108.5	93.0	3.0	0.0	0.0	0.9	0.0	5.4	54.4	0.1	0.1	6.7	0.2	0.1	0.0	0.0	0.6	1.8	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	1.8	0.0	13.2	0.2	0.2	14.4	0.3	2.6	0.0	29.7	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.4	4.2	0.0	0.0	0.0	123.4	0.2	4.8	0.0	0.5	0.2	0.1	0.1	0.1	3.2	0.0	0.1	0.0	1.3	0.3	0.2	2.9	0.4	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.5	2.4	1.5	2.0	3.4	2.2	2.7	3.1	2.4	3.0	8.0	0.0	1.1	0.0	0.1	11.3	0.4	2.1	75.1	0.1	1.8	25.3	13.2	0.0	4.3	1.8	0.0	34.4	0.3	0.0	0.0	0.0	1.0	6.9	97.0	7.8	0.0	0.0	5.6	0.0	4.0	235.9	6.1	11.3	3.8	0.2	18.5	0.0	6.2	0.0	5.2	0.0	0.0	0.0	18.5	1.4	14.6	1.7	5.4	5.6	0.0	0.1	0.0	1.0	3.3	0.0	0.0	15.4	0.5	0.6	0.0	0.0	0.1	0.5	0.0	4.2	118.2	4.4	2.8	3.9	9.7	25.3	2.7	4.5	0.0	0.3
COLGALT2	"C1orf17, GLT25D2, KIAA0584"	ENSG00000198756	"Collagen beta(1-O)galactosyltransferase 2"	Q8IYK4	1	183929854-184037729	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 50.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.5;Excitatory neurons: 79.9;Inhibitory neurons: 71.5;Late spermatids: 76.2;Oligodendrocyte precursor cells: 115.1;Oligodendrocytes: 359.3"	"Cancer enhanced"	"Detected in many"		"glioma: 11.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"basophil: 11.1"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.1;OE19: 13.8;SK-MEL-30: 18.6;U-251 MG: 18.0;WM-115: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031749, HPA031750"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Vesicles	"HPA031749: AB_10599298, HPA031750: AB_10611252"	"unprognostic (5.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.29e-5)"	"unprognostic (2.08e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.13e-9)"	"unprognostic (1.53e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.80e-2)"	1.7	6.4	15.7	0.8	29.3	1.1	1.5	22.7	18.6	1.0	0.0	4.3	0.5	1.8	3.1	0.7	2.8	2.3	11.4	16.5	17.3	0.8	0.2	3.7	0.3	26.8	24.0	1.3	2.3	0.5	2.2	0.1	28.7	5.3	0.9	3.5	2.9	2.2	8.8	0.3	1.0	1.7	20.2	0.5	1.9	3.5	25.8	0.3	3.3	6.3	0.5	1.8	1.5	50.6	0.1	0.0	5.7	0.4	3.0	4.4	0.1	1.8	0.7	0.8	1.0	2.8	0.2	0.0	0.5	4.4	1.1	0.0	5.6	0.0	1.4	6.6	3.3	0.4	0.0	17.1	0.1	6.0	0.1	2.6	0.0	0.8	0.1	8.4	0.0	0.2	5.7	7.2	6.1	0.2	0.3	0.3	3.9	13.8	0.0	0.5	0.0	0.0	0.0	1.2	2.2	3.5	0.3	0.0	18.6	3.7	0.0	0.3	0.1	0.7	0.7	0.1	18.0	10.8	0.1	0.1	0.5	2.8	22.5	11.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	15.7	29.3	22.7	18.6	16.5	17.3	26.8	24.0	28.7	20.2	25.8	50.6	0.1	0.0	0.0	53.5	0.0	0.4	0.5	0.0	0.0	4.4	0.3	0.3	3.5	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.6	40.3	0.2	0.5	0.9	0.0	1.3	79.9	0.0	0.0	9.9	1.5	0.5	0.0	0.2	0.0	0.1	0.3	0.0	71.5	0.1	0.0	0.3	9.5	76.2	2.1	0.9	1.8	4.7	0.0	5.7	8.2	115.1	359.3	1.2	0.0	4.1	1.9	0.2	0.0	0.3	0.0	0.4	13.1	2.3	3.1	0.3	1.3	0.0	0.4	0.0	4.5	0.4	0.0	0.4
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150794880-150809577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 420.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 18.1"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.8"	"Group enriched"	"Detected in many"	9	"ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	224.1	12.5	2.7	33.1	2.8	3.1	227.7	2.9	18.1	420.6	16.4	68.6	13.8	334.0	44.9	46.0	74.0	299.2	35.8	2.7	2.6	12.7	9.0	36.4	42.1	2.7	2.7	78.4	10.6	6.1	14.6	18.9	2.6	34.1	61.8	6.9	53.3	38.0	15.7	219.8	63.8	141.6	2.8	20.2	41.7	15.1	2.7	12.3	34.7	46.3	48.7	210.5	176.2	2.9	0.7	0.3	1.4	0.8	2284.0	813.2	1.0	55.2	1949.1	3.3	8.3	0.3	0.3	0.4	0.6	129.8	0.0	0.6	0.3	0.4	1.2	0.4	0.4	1.4	0.5	0.0	11.0	0.2	1.3	156.5	1.7	50.5	0.7	137.6	4.2	0.6	0.4	1.4	1.5	1.4	0.0	3.0	10.2	1.0	0.0	0.2	0.1	0.1	3.2	0.1	0.6	2.9	0.4	0.0	29.3	3.9	1.0	1.5	1.0	0.7	0.5	0.6	0.6	2.3	1.7	3.6	184.1	0.0	9.9	0.0	1.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.4	0.6	2.7	2.8	2.9	18.1	2.7	2.6	2.7	2.7	2.6	2.8	2.7	2.9	17.9	3.2	4.6	2.6	1.1	68.8	0.5	1.6	2.2	12.1	3.7	9.5	2.0	1.5	3.9	3.7	4.2	1.3	2.8	1.5	0.0	1.0	0.9	2.5	59.0	10.2	1.2	0.8	5.0	0.2	2.5	372.4	11.2	3.8	0.0	77.5	14.6	0.5	21.4	3.3	7.7	1.6	8.2	4.6	123.6	4.4	119.0	8.7	97.8	7.5	4.9	2.7	3.1	7.1	2.5	1.4	1.4	149.7	0.8	1.0	1.4	0.1	2.2	7.7	13.1	4.5	33.9	1.4	1.0	2.6	59.1	1.0	5.4	80.9	1.0	0.7
CXCL12	"PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1"	ENSG00000107562	"C-X-C motif chemokine ligand 12"	P48061	10	44370165-44386493	"Predicted secreted proteins"	"Chemotaxis, Host-virus interaction"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 347.2;Distal tubular cells: 172.1;Fibroblasts: 566.4;Kupffer cells: 191.8;Smooth muscle cells: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 509.6;BJ hTERT+: 303.5;BJ hTERT+ SV40 Large T+: 294.9;BJ hTERT+ SV40 Large T+ RasG12V: 441.2;fHDF/TERT166: 501.8;HSkMC: 1293.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017564	Approved				"Secreted to blood"	NA	NA	1030000	560000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017564: AB_2088170"	"unprognostic (2.41e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	366.8	82.6	19.4	143.8	20.2	35.1	237.4	19.1	28.1	268.4	24.5	124.3	53.6	360.7	54.3	138.5	122.1	263.3	190.3	19.4	18.6	124.8	252.8	71.0	215.8	22.3	21.1	112.3	131.2	126.7	21.3	8.5	19.1	47.8	115.5	2.1	116.3	66.2	158.9	99.4	96.5	343.5	19.9	356.6	45.4	19.4	21.0	142.6	103.4	181.3	119.7	107.0	174.3	17.7	0.0	0.0	0.4	0.6	509.6	78.9	0.4	187.7	303.5	294.9	441.2	0.0	0.1	0.2	1.9	501.8	0.0	0.1	0.8	0.2	97.1	187.2	2.4	0.0	0.0	0.0	172.8	0.4	0.9	1293.8	0.0	63.8	0.1	0.0	0.2	0.1	0.1	0.0	1.0	0.4	0.7	0.6	32.2	0.0	0.6	0.8	0.3	224.3	0.2	0.0	0.6	0.6	0.3	0.7	0.0	63.6	272.2	0.4	0.4	0.4	0.5	205.0	0.2	0.2	0.1	0.1	0.6	0.3	3.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	20.2	19.1	28.1	19.4	18.6	22.3	21.1	19.1	19.9	21.0	17.7	347.2	0.0	1.1	1.3	1.4	76.3	0.3	0.0	9.6	1.5	8.1	14.0	25.0	10.0	0.6	5.5	0.0	0.3	2.1	0.0	172.1	0.8	2.2	1.7	46.8	134.1	0.0	0.0	0.6	20.5	0.3	566.4	1.5	1.0	0.0	0.4	55.6	2.5	2.6	0.0	6.6	3.9	0.0	191.8	110.1	3.7	70.2	27.9	135.2	74.0	0.0	1.9	0.0	12.1	0.1	3.0	0.0	8.6	1.0	1.0	0.1	25.5	0.0	0.8	85.5	43.7	146.1	1.8	5.9	6.3	62.7	0.7	9.6	33.2	0.5	0.5
CYS1		ENSG00000205795	"Cystin 1"	Q717R9	2	10056780-10080944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 124.6;pancreas: 33.6"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 32.9;Collecting duct cells: 51.5;Distal tubular cells: 70.5;Muller glia cells: 48.0;Proximal tubular cells: 54.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"RPTEC TERT1: 111.5"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (8.48e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (2.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.20e-2)"	3.1	1.6	6.0	1.2	5.7	0.0	1.9	5.3	7.8	8.4	15.5	11.7	2.5	7.8	3.6	3.9	6.3	9.1	6.1	5.5	5.5	124.6	1.0	6.1	1.1	6.9	6.0	12.4	33.6	1.7	7.2	0.1	5.6	4.9	1.8	2.2	2.9	7.2	1.0	1.5	3.4	5.9	6.4	2.9	3.9	1.0	5.2	0.5	5.6	2.1	2.1	3.5	6.6	5.9	0.0	0.3	0.0	0.0	0.5	2.6	0.1	0.4	1.6	0.2	0.1	0.2	0.0	0.0	0.4	4.4	0.9	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	111.5	0.0	0.0	0.5	0.4	0.3	0.0	1.3	2.0	0.2	0.0	6.0	3.2	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	5.7	5.3	7.8	5.5	5.5	6.9	6.0	5.6	6.4	5.2	5.9	0.9	6.4	1.1	1.0	1.0	0.5	0.1	0.6	0.0	10.3	0.5	5.5	7.3	32.9	0.0	51.5	0.0	0.0	0.2	0.0	70.5	7.0	0.1	0.3	0.9	0.6	0.0	0.0	2.9	1.1	0.6	8.8	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.3	0.0	3.4	1.0	0.0	2.8	0.0	48.0	0.0	3.0	0.6	0.4	0.0	4.5	0.1	0.3	0.0	54.1	0.0	1.9	0.0	0.5	3.9	0.0	1.4	0.0	0.1	0.0	0.3	0.1	0.0	0.1
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
DENND2A	"FAM31D, KIAA1277"	ENSG00000146966	"DENN domain containing 2A"	Q9ULE3	7	140518420-140673993	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 114.9;Horizontal cells: 89.2;Oligodendrocyte precursor cells: 72.4;Paneth cells: 69.5"	"Cancer enriched"	"Detected in all"	6	"glioma: 28.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 57.7;BJ hTERT+: 60.8;PC-3: 29.1;RPTEC TERT1: 72.7;U-2197: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (5.02e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (3.05e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.38e-3)"	15.4	3.9	28.9	2.5	32.5	0.6	11.0	23.5	25.8	25.0	46.9	12.0	3.9	26.2	5.1	9.6	30.7	11.1	16.1	25.2	28.8	14.5	3.1	17.6	2.3	43.7	39.7	21.7	2.2	5.0	26.3	15.5	33.7	11.4	5.6	11.5	2.6	5.4	7.1	3.9	8.9	16.0	34.6	12.2	6.6	2.1	32.1	0.8	3.7	7.8	1.8	12.1	11.4	26.2	0.2	0.9	57.7	0.5	6.2	1.1	12.4	2.2	60.8	9.5	15.3	0.0	0.1	0.1	0.4	0.6	10.2	0.2	11.0	0.8	17.8	0.0	1.0	0.0	0.2	0.0	1.6	0.2	0.1	2.8	0.6	13.9	2.1	24.9	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.3	12.3	0.1	29.1	2.1	3.7	0.2	72.7	0.1	4.6	14.5	0.0	0.0	0.0	16.7	0.1	0.6	0.0	10.9	2.2	32.1	5.9	0.3	0.0	0.1	0.9	0.1	3.9	1.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	1.2	0.3	0.1	0.2	0.1	0.0	28.9	32.5	23.5	25.8	25.2	28.8	43.7	39.7	33.7	34.6	32.1	26.2	13.8	0.0	3.0	34.9	0.5	1.3	1.9	0.1	0.6	7.4	1.9	1.0	4.3	0.0	1.3	0.0	8.4	1.0	0.3	114.9	7.9	0.0	1.4	0.4	8.3	4.6	9.6	0.0	10.0	0.0	4.9	14.8	1.1	0.3	11.4	22.4	9.7	0.7	2.4	89.2	23.2	37.1	0.0	0.3	2.1	1.0	18.6	0.6	1.8	32.8	0.1	16.2	0.0	72.4	42.3	0.1	69.5	10.5	0.0	2.2	3.8	0.1	1.0	10.5	13.1	11.8	11.3	0.1	0.9	0.2	0.4	0.4	1.1	0.2	42.7	1.2
DOK6	"DOK5L, HsT3226, MGC20785"	ENSG00000206052	"Docking protein 6"	Q6PKX4	18	69400888-69849087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;parathyroid gland: 12.5;retina: 22.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 230.4;Excitatory neurons: 236.8;Inhibitory neurons: 259.1;Oligodendrocyte precursor cells: 178.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.5;Hep G2: 11.1;RPMI-8226: 10.5;SCLC-21H: 4.7;SH-SY5Y: 10.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041099, HPA063534"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	"Focal adhesion sites, Cytosol"		"HPA041099: AB_2677299, HPA063534: AB_2685032"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.62e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.13e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.09e-3)"	1.1	0.7	8.8	0.7	10.3	0.1	0.5	0.9	14.0	1.8	0.0	0.6	0.3	1.5	0.5	0.7	0.7	3.2	6.2	17.8	10.6	4.9	2.4	2.4	0.5	10.9	11.6	2.2	0.2	12.5	0.7	5.9	9.7	1.3	0.5	22.3	0.8	2.1	0.1	0.5	0.5	2.5	4.1	0.9	0.7	1.5	6.5	0.1	2.2	0.6	0.5	3.1	1.1	5.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.0	11.1	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.5	0.0	0.0	4.7	10.5	0.0	0.0	0.0	7.6	0.0	0.0	0.0	4.0	0.6	0.0	1.5	0.3	0.0	0.0	3.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.3	0.9	14.0	17.8	10.6	10.9	11.6	9.7	4.1	6.5	5.8	0.5	0.0	0.0	9.8	0.0	0.3	0.1	0.0	0.0	230.4	0.1	0.0	9.1	0.0	1.3	0.0	14.6	0.0	1.2	0.0	1.9	0.0	45.3	0.4	13.3	1.5	0.0	0.0	236.8	0.0	0.0	6.7	0.0	0.3	0.0	17.2	0.0	0.9	0.0	10.1	259.1	0.0	0.0	0.3	0.8	30.6	1.5	2.1	0.0	8.4	0.1	6.9	2.1	178.4	6.4	0.0	0.0	6.8	0.7	0.1	0.0	9.6	0.0	14.6	0.0	0.4	5.5	0.9	1.1	0.1	0.6	0.0	1.2	4.9	0.0	0.1
DSCAML1	KIAA1132	ENSG00000177103	"DS cell adhesion molecule like 1"	Q8TD84	11	117427772-117817525	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 27.0;retina: 20.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 87.9;Excitatory neurons: 178.8;Inhibitory neurons: 232.4;Oligodendrocyte precursor cells: 352.8;Oligodendrocytes: 465.3;Rod photoreceptor cells: 137.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;renal cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;HDLM-2: 1.7;RPTEC TERT1: 4.8;T-47d: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035230	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035230: AB_2674527"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.27e-5)"	"unprognostic (8.48e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.39e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-2)"	1.5	0.3	8.4	0.1	12.6	0.2	0.4	4.3	12.4	1.0	0.0	2.0	0.4	2.0	0.5	0.2	2.7	1.2	1.0	11.0	10.2	3.0	0.4	0.7	0.3	13.2	12.7	5.0	0.9	0.0	4.3	0.1	12.3	0.8	0.6	20.1	1.1	0.3	0.5	0.2	0.7	0.8	2.9	1.0	0.7	2.1	14.9	0.5	0.7	0.3	0.4	1.2	0.7	27.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.9	0.1	0.0	0.0	0.0	0.3	9.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	8.4	12.6	4.3	12.4	11.0	10.2	13.2	12.7	12.3	2.9	14.9	27.0	0.4	0.0	0.0	23.8	0.1	0.1	0.1	0.1	0.6	87.9	0.0	0.0	2.7	4.3	0.1	0.0	41.7	0.0	0.0	0.3	0.0	0.4	6.1	2.1	0.3	0.7	6.7	0.0	178.8	0.0	0.0	1.3	0.0	0.4	0.0	0.2	0.7	0.0	0.1	3.3	232.4	3.7	0.0	0.0	1.2	10.5	1.2	0.2	0.0	3.7	0.0	4.0	0.0	352.8	465.3	0.0	0.1	1.9	0.0	0.2	0.0	1.8	5.5	137.7	0.0	1.2	1.2	0.3	0.8	0.0	0.0	0.1	0.3	0.1	0.9	0.1
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 484.1;esophagus: 1370.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 113.3;Fibroblasts: 118.6;Melanocytes: 74.7;Pancreatic endocrine cells: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 402.1;BJ hTERT+: 293.1;fHDF/TERT166: 279.6;hTEC/SVTERT24-B: 195.6;LHCN-M2: 215.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		8700000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	49.3	15.4	7.6	11.8	8.5	0.8	27.1	7.3	14.7	293.8	6.1	17.7	9.4	51.2	484.1	1370.5	20.1	76.5	81.3	8.1	8.3	15.9	61.2	26.3	1.2	17.4	8.9	8.9	4.1	3.5	12.7	44.6	15.4	15.5	18.1	0.9	223.9	14.0	7.0	70.0	12.4	32.6	8.9	11.5	12.4	2.7	9.4	1.3	11.1	7.8	135.0	24.4	360.1	10.7	35.4	3.5	12.6	0.2	73.9	402.1	11.4	126.9	293.1	76.2	99.5	1.9	19.1	0.6	1.3	279.6	8.8	71.5	0.2	15.0	79.3	0.6	0.7	5.7	4.1	0.7	20.4	0.3	125.5	35.7	0.9	195.6	7.2	112.8	21.3	0.7	27.7	0.8	215.2	0.1	0.4	4.2	1.4	147.8	4.1	2.0	92.7	0.5	2.8	0.1	0.8	0.4	28.8	0.9	106.4	5.8	0.3	34.0	5.8	159.3	23.9	18.3	27.9	0.5	1.1	1.5	84.6	11.7	22.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	8.5	7.3	14.7	8.1	8.3	17.4	8.9	15.4	8.9	9.4	10.7	9.1	0.0	1.1	2.9	0.6	14.7	1.9	6.9	0.0	0.7	0.5	0.6	1.8	7.2	7.9	3.7	0.0	2.2	0.6	1.0	0.0	6.2	0.3	3.1	113.3	15.7	0.0	0.0	12.1	4.3	40.9	118.6	7.7	2.5	10.2	1.0	42.5	1.0	17.0	1.7	10.9	1.4	18.3	2.2	22.8	0.3	9.9	10.8	74.7	2.8	0.1	0.5	0.0	1.0	4.4	70.2	1.1	22.2	0.4	1.5	0.1	0.1	0.4	1.2	13.1	4.1	32.3	0.7	0.6	28.1	19.0	10.9	2.1	5.0	0.5	6.9
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 73.3;Hepatocytes: 49.3;Leydig cells: 122.1;Peritubular cells: 69.6;Skeletal myocytes: 43.6;Smooth muscle cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 19.1;ASC TERT1: 34.5;HSkMC: 36.8;hTCEpi: 42.8;hTERT-HME1: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035347, HPA035348"	Approved		Approved	"Mitotic spindle,Centrosome,Cytosol"	"Secreted to extracellular matrix"	Yes	NA		10000000		"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Centrosome, Cytosol"	"Mitotic spindle"	"HPA035347: AB_10669856, HPA035348: "	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	122.1	14.3	5.0	2.1	5.0	0.6	34.8	6.0	4.9	43.5	8.1	6.8	9.0	40.8	23.2	9.0	30.0	31.7	31.5	4.5	11.6	28.4	81.5	22.5	8.3	5.2	10.3	91.6	6.3	9.1	6.1	3.5	5.8	21.2	7.4	0.3	7.2	22.2	7.4	9.7	14.8	27.8	4.4	0.9	4.3	16.8	8.0	5.0	11.4	24.6	7.8	13.3	11.1	12.0	0.7	0.1	0.4	0.0	19.1	34.5	1.3	0.8	1.1	0.1	0.5	0.6	0.0	0.0	0.1	1.9	0.3	0.5	0.9	0.8	0.1	4.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	36.8	42.8	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.1	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.0	6.0	4.9	4.5	11.6	5.2	10.3	5.8	4.4	8.0	12.0	12.9	0.0	2.3	5.5	0.3	11.5	0.1	0.6	0.6	3.0	0.3	1.3	5.5	1.5	2.0	0.0	2.1	0.1	0.3	0.2	0.0	0.1	5.1	0.6	18.6	5.2	0.0	0.8	3.4	0.0	16.2	73.3	0.5	0.5	0.0	18.2	2.2	49.3	0.4	0.0	2.8	0.4	0.0	1.3	15.4	8.9	122.1	1.1	5.4	17.8	0.1	0.1	0.0	0.5	2.9	0.0	0.2	69.6	1.4	0.1	11.1	9.2	3.3	2.5	26.3	43.6	50.2	0.9	0.6	0.9	9.1	0.8	0.9	13.5	0.6	0.2
EDIL3	DEL1	ENSG00000164176	"EGF like repeats and discoidin domains 3"	O43854	5	83940554-84384880	"Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 256.8"	"Group enriched"	"Detected in many"	6	"Oligodendrocyte precursor cells: 561.4;Oligodendrocytes: 2119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 547.0;LHCN-M2: 169.8;TIME: 203.3;U-2 OS: 163.2;U-87 MG: 112.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020415	Approved				"Secreted to blood"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA020415: AB_2670434"	"unprognostic (9.93e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-3)"	13.9	21.7	55.3	13.6	126.6	0.2	6.2	93.9	105.1	17.5	7.6	37.0	17.0	26.8	44.9	17.0	10.9	34.0	20.6	68.1	90.1	10.7	0.7	20.9	0.8	118.1	89.3	10.1	3.4	4.2	2.9	4.6	121.0	13.5	38.4	40.2	3.9	22.1	0.8	9.7	26.2	25.8	99.1	3.2	19.7	2.3	82.3	0.3	4.0	0.7	3.6	15.7	9.5	256.8	0.1	1.5	1.4	0.0	3.7	0.2	0.1	4.8	0.0	12.6	16.9	0.0	21.2	0.0	0.1	0.1	8.8	19.6	0.0	0.8	9.3	0.1	9.2	0.0	54.5	0.0	99.9	1.0	0.2	25.6	2.6	61.0	8.5	547.0	21.7	0.0	0.0	0.3	169.8	0.1	0.1	0.3	8.7	0.0	39.4	0.1	41.4	0.1	28.2	0.0	4.5	0.5	0.0	0.3	0.1	26.1	0.2	0.2	203.3	60.8	163.2	2.1	56.6	1.6	0.0	0.1	112.6	0.1	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	126.6	93.9	105.1	68.1	90.1	118.1	89.3	121.0	99.1	82.3	256.8	3.1	9.6	6.0	14.0	0.1	12.1	1.7	13.7	14.8	179.2	0.3	11.7	13.3	0.0	4.5	3.7	2.1	0.3	0.1	5.9	0.0	0.1	32.8	0.4	7.2	10.4	22.9	0.0	219.9	0.0	0.0	34.8	0.0	0.3	5.7	1.3	1.4	0.1	0.3	5.0	216.5	9.2	2.0	0.0	3.3	19.8	2.5	0.3	3.6	32.8	0.0	5.4	0.0	561.4	2119.7	0.4	8.1	3.8	0.0	0.9	0.0	0.9	1.2	11.6	6.6	0.2	40.2	1.9	1.5	9.3	16.1	0.4	0.6	16.2	8.4	0.7
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.7;Cytotrophoblasts: 1365.8;Fibroblasts: 309.7;Syncytiotrophoblasts: 889.6"	"Cancer enhanced"	"Detected in all"		"glioma: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 953.6;hTERT-RPE1: 2226.5;HUVEC TERT2: 4270.9;TIME: 3554.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1900000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	240.5	55.7	57.0	57.2	82.8	0.2	115.3	57.1	88.8	54.9	180.7	74.6	22.5	73.2	128.4	51.5	134.8	140.4	187.8	47.5	75.6	57.4	12.9	150.1	27.2	80.8	121.1	175.1	29.2	17.6	22.6	329.7	65.5	58.4	91.0	42.8	87.7	161.2	14.7	55.2	45.3	93.5	72.2	42.4	46.9	8.0	71.0	16.8	139.1	93.8	21.2	203.9	77.3	71.9	358.4	3.1	8.5	0.3	320.9	217.1	0.8	208.1	233.7	25.2	20.5	0.0	18.0	0.5	140.4	234.3	22.1	323.4	1.6	234.6	8.9	1.0	1.0	0.3	87.4	0.2	843.2	0.3	0.6	953.6	117.5	21.9	260.9	2226.5	4270.9	0.5	1.2	0.2	99.2	36.7	2.6	0.5	4.2	0.1	0.8	0.2	0.3	0.9	9.8	7.3	2.0	0.4	284.6	105.0	0.7	8.1	289.8	1.5	3554.3	1.5	107.5	397.9	138.5	13.7	0.5	1.4	73.1	0.3	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	82.8	57.1	88.8	47.5	75.6	80.8	121.1	65.5	72.2	71.0	71.9	26.6	250.0	109.1	234.1	0.1	79.4	79.1	367.7	42.1	2.8	6.2	78.2	12.5	12.8	98.2	27.6	0.0	1365.8	0.4	0.0	9.8	36.2	0.5	2.2	38.9	73.5	0.0	0.0	1.0	25.6	173.0	309.7	6.1	2.1	2.5	3.9	48.5	0.7	94.9	0.0	4.7	0.0	40.7	0.8	33.9	0.9	42.6	3.2	17.8	6.5	0.6	137.3	0.0	2.5	0.8	2.8	0.0	0.0	1.5	24.2	0.0	14.7	88.8	4.7	0.0	7.0	28.7	0.4	1.8	6.0	31.7	889.6	5.0	61.3	0.0	6.2
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107621-89482134	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 31.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 70.6;Inhibitory neurons: 106.6;Microglial cells: 103.0;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	5.4	1.0	2.1	1.8	1.3	0.0	2.3	0.2	3.8	12.3	0.1	3.8	2.3	5.5	0.2	3.2	1.3	18.8	8.2	2.2	0.7	1.3	4.9	2.4	3.6	3.3	0.9	4.1	2.1	1.0	0.9	20.1	4.0	31.5	6.2	8.0	2.2	7.1	0.8	0.7	2.4	7.9	0.8	0.9	2.5	1.0	1.7	1.0	11.0	6.3	3.2	14.3	6.4	2.2	0.0	0.0	197.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	11.2	0.2	0.7	0.0	2.4	0.0	0.0	11.8	0.0	0.0	1.7	2.0	0.0	3.9	0.0	0.0	0.6	0.0	2.5	0.1	0.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.5	0.1	0.1	36.1	0.1	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.3	0.2	3.8	2.2	0.7	3.3	0.9	4.0	0.8	1.7	2.2	2.2	0.0	0.0	5.5	0.0	0.5	0.3	0.0	0.6	6.4	0.0	0.1	2.4	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.5	1.8	0.0	0.0	70.6	0.0	0.1	18.1	0.5	0.0	0.0	0.0	1.1	0.0	0.1	20.2	106.6	0.0	0.0	0.0	0.7	1.6	2.1	0.1	0.0	103.0	0.0	4.7	0.0	2.5	48.0	0.0	0.0	8.2	0.0	0.1	0.0	0.0	0.0	18.7	6.6	0.7	19.2	0.1	0.0	0.3	0.3	0.5	0.2	1.3	0.0	0.1
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122799-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 160.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 113.6;Hepatocytes: 195.1;Leydig cells: 215.9;Peritubular cells: 236.2"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 14.4;BJ hTERT+: 11.5;CACO-2: 12.7;fHDF/TERT166: 13.1;Hep G2: 59.6;HHSteC: 11.5;SH-SY5Y: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA		13000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	21.3	8.5	1.1	1.5	1.2	0.0	11.7	2.5	2.0	53.8	1.4	5.6	10.9	13.2	16.4	8.9	23.9	10.9	40.7	1.1	1.8	4.1	160.0	14.4	3.2	2.6	1.5	27.9	7.1	0.2	4.5	4.4	2.5	12.8	2.0	0.9	5.1	7.1	6.8	20.7	11.9	2.7	1.3	3.2	8.6	10.1	1.4	1.4	8.3	6.6	1.3	11.9	25.8	1.1	0.1	0.0	2.5	0.4	8.0	8.1	0.1	14.4	11.5	0.8	0.3	12.7	0.1	0.1	0.5	13.1	1.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	59.6	11.5	0.0	0.3	8.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	1.5	0.1	0.0	0.3	0.0	1.3	0.2	0.3	0.1	0.0	0.0	0.2	1.0	27.9	0.1	0.5	0.1	0.6	0.6	0.1	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	2.5	2.0	1.1	1.8	2.6	1.5	2.5	1.3	1.4	1.1	7.0	0.0	0.0	1.3	0.6	15.7	0.1	0.0	0.0	1.1	0.4	0.3	9.1	4.3	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.1	2.9	1.9	45.9	3.8	17.9	2.7	1.3	0.0	0.4	113.6	6.1	1.0	1.3	2.2	7.9	195.1	1.4	6.7	1.4	5.0	0.0	4.8	25.0	9.6	215.9	1.3	19.6	5.6	0.6	4.5	0.0	0.5	0.1	0.3	6.5	236.2	0.0	0.3	28.3	6.4	0.0	1.2	52.6	14.5	40.9	2.3	1.2	0.5	15.3	1.1	1.9	2.4	2.2	0.4
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	359.3	123.1	17.3	72.3	29.5	1.7	318.2	27.8	27.5	1131.0	802.4	200.7	75.5	410.6	126.0	305.8	497.6	676.1	773.7	47.0	11.9	61.3	15.7	414.9	16.1	21.8	24.5	214.1	106.3	216.9	90.3	505.7	23.1	466.8	83.6	3.1	121.2	158.5	36.0	296.3	174.5	180.3	15.9	24.9	269.1	21.9	24.7	20.5	195.3	47.5	13.0	704.6	940.5	14.6	17.7	41.6	122.9	258.0	1839.4	809.8	559.8	1029.3	1615.9	89.8	33.8	179.2	5.2	0.4	42.8	38.6	2.5	90.9	78.0	2.7	10.8	0.9	21.0	0.4	209.4	121.5	243.2	1.0	1.0	1345.8	15.8	89.6	32.7	1.8	0.2	1.4	0.9	2.1	63.3	2.4	0.8	3.2	173.8	3.7	15.4	1.4	0.9	2.1	41.1	1485.2	8.7	162.7	127.5	589.6	0.6	344.3	3.7	5.4	8.0	17.4	109.3	465.8	1.0	1.6	0.8	1.4	1.2	1.0	43.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.0	2.4	1.2	0.0	0.1	17.3	29.5	27.8	27.5	47.0	11.9	21.8	24.5	23.1	15.9	24.7	14.6	34.4	6.4	1.3	34.3	1.2	170.9	113.4	54.8	21.1	0.1	5.3	11.6	20.1	10.0	28.3	1.8	0.0	666.3	1.6	0.1	0.0	1.3	10.5	61.5	628.2	34.5	0.0	0.0	0.5	0.2	651.6	1506.5	38.7	256.5	1.3	29.0	22.1	0.6	82.4	0.0	0.8	0.3	6.1	0.0	222.9	25.4	92.2	11.4	170.7	41.2	0.0	0.1	0.0	0.0	0.4	1.0	0.1	30.5	4.5	47.4	0.0	0.3	10.2	0.6	118.3	37.1	81.5	42.2	68.7	23.8	130.3	1215.9	18.2	2.3	0.4	86.9
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549125-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 292.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 92.7;Endometrial stromal cells: 84.4;Fibroblasts: 458.4;Leydig cells: 170.9;Peritubular cells: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 6.7;naive CD8 T-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 384.0;fHDF/TERT166: 264.3;HMC-1: 311.6;HSkMC: 221.9;U-2197: 139.2"	"Group enriched"	"Detected in many"	4	"olfactory bulb: 12.4;white matter: 3.1"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		35000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	157.3	7.6	5.9	12.7	7.7	1.0	97.3	5.2	9.0	63.4	6.4	32.7	6.2	31.1	3.2	42.4	26.8	46.2	292.8	7.0	4.9	8.7	3.7	29.2	8.4	5.3	5.3	5.8	8.6	3.0	2.3	80.3	4.8	29.1	11.8	0.6	39.4	8.8	47.7	72.5	19.8	14.7	4.1	6.0	22.3	46.7	6.9	14.2	63.7	48.9	5.6	79.6	56.7	4.4	0.0	1.4	50.9	0.0	384.0	51.7	23.8	124.9	98.2	122.4	80.4	8.1	0.3	0.0	5.9	264.3	0.2	0.2	0.0	0.5	22.9	0.1	0.1	100.7	1.9	0.0	26.0	0.2	311.6	221.9	2.0	19.3	0.0	0.2	0.0	8.6	0.8	0.9	0.6	0.3	5.2	0.6	12.2	0.0	0.7	0.2	0.0	0.5	0.9	0.1	3.0	2.4	0.5	90.3	0.1	13.6	0.2	0.3	0.1	0.1	0.1	139.2	0.1	0.2	0.0	0.0	1.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.2	6.7	1.3	0.0	3.7	0.0	0.2	0.0	0.5	0.0	0.9	5.9	7.7	5.2	9.0	7.0	4.9	5.3	5.3	4.8	4.1	6.9	4.4	92.7	0.0	1.5	1.6	3.6	30.8	0.8	10.5	2.2	0.0	1.7	1.9	8.8	0.0	12.3	7.3	2.1	7.8	1.9	0.1	0.0	0.0	3.8	2.9	84.4	43.8	0.0	1.7	0.6	0.2	4.8	458.4	6.1	2.7	23.6	0.6	47.8	0.4	3.6	0.0	0.6	0.0	0.0	1.9	49.8	12.1	170.9	4.5	39.2	26.2	0.3	1.2	0.0	30.7	0.3	0.3	0.0	227.2	1.6	1.2	2.7	0.1	1.4	0.4	13.1	29.7	26.4	3.4	13.5	2.0	28.8	6.2	5.3	0.2	0.0	1.1
FKBP7	FKBP23	ENSG00000079150	"FKBP prolyl isomerase 7"	Q9Y680	2	178463664-178478600	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.1;Endometrial stromal cells: 54.8;Fibroblasts: 67.6;Leydig cells: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 155.0;ASC TERT1: 96.7;fHDF/TERT166: 60.9;HSkMC: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.3	5.4	1.5	3.9	1.6	1.4	11.9	2.6	2.8	23.1	1.5	8.3	2.8	27.8	11.3	5.9	15.1	15.4	12.3	1.6	1.8	5.2	8.3	7.8	2.9	1.6	1.5	50.0	2.8	2.7	5.0	13.0	1.5	9.3	6.2	2.1	5.0	13.3	3.8	4.2	4.4	19.2	1.2	3.0	5.4	4.4	1.5	2.5	6.6	6.5	2.8	11.6	10.2	2.1	0.2	1.9	18.5	27.8	155.0	96.7	1.7	33.3	55.0	5.9	19.0	0.3	1.9	5.4	7.3	60.9	5.5	0.3	7.1	2.8	10.3	4.5	3.9	5.7	7.3	5.5	23.7	3.5	3.8	64.7	1.4	24.0	3.4	44.2	19.8	6.6	2.5	3.4	25.2	0.3	6.1	6.0	3.6	3.5	2.9	7.8	31.9	7.7	8.4	0.6	9.7	32.0	7.0	0.2	6.2	12.7	0.5	6.8	18.2	11.0	6.8	12.8	3.2	6.3	7.2	2.6	19.9	8.7	24.3	0.0	0.4	0.0	1.0	0.7	1.2	1.1	0.9	0.7	2.6	0.7	0.9	1.0	0.0	0.6	0.0	2.1	1.1	0.4	1.5	1.6	2.6	2.8	1.6	1.8	1.6	1.5	1.5	1.2	1.5	2.1	16.2	6.4	4.1	2.9	5.4	7.0	9.3	19.6	7.4	4.2	6.7	13.6	16.1	2.8	5.2	7.3	0.0	7.6	2.7	0.7	1.9	10.9	149.1	3.4	54.8	19.3	1.2	4.2	1.6	8.4	22.4	67.6	4.1	3.5	14.0	19.0	15.7	11.9	5.8	5.0	3.7	5.6	14.2	4.4	13.6	27.1	64.0	3.8	17.8	4.7	1.6	4.2	1.0	7.1	4.2	3.9	0.7	48.5	10.3	3.4	0.4	3.7	2.1	3.6	6.6	31.1	37.7	8.5	5.1	3.7	5.8	5.1	5.5	30.4	3.1	4.1
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44143213-44198170	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 12.6;choroid plexus: 7.4;heart muscle: 8.8;liver: 21.5;pituitary gland: 23.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.3;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	0.8	0.3	8.9	0.3	8.3	0.2	0.7	8.1	9.5	2.8	7.4	0.5	0.1	1.2	0.8	0.4	1.2	0.5	8.8	8.2	11.0	1.2	21.5	0.4	0.2	9.0	9.9	1.4	1.8	0.1	23.9	1.6	9.1	1.2	0.2	1.0	0.3	0.7	0.2	0.7	0.5	0.3	8.3	0.6	0.6	0.4	12.6	0.1	0.5	0.1	0.2	1.1	2.0	7.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.2	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.3	2.3	0.7	0.1	0.1	0.3	2.0	0.4	0.8	0.1	0.0	0.1	0.0	0.3	8.9	8.3	8.1	9.5	8.2	11.0	9.0	9.9	9.1	8.3	12.6	7.9	0.3	0.0	0.0	0.7	0.3	1.1	0.7	0.0	1.2	5.0	0.1	0.8	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.5	2.4	0.0	1.8	0.0	0.2	5.2	0.0	0.0	0.0	2.4	0.0	0.4	0.7	5.0	2.4	0.0	0.0	0.0	0.7	0.3	0.9	0.1	0.0	1.0	0.0	2.8	0.0	0.5	1.0	0.1	0.1	2.2	0.2	1.7	0.0	0.1	0.0	0.8	0.0	0.6	3.7	0.5	1.1	0.0	0.1	0.8	0.3	0.5	0.0	0.7
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273284	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		140000		"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	10.9	3.4	7.2	4.2	14.9	0.0	23.2	2.6	9.5	9.9	0.3	18.3	1.7	4.9	20.5	6.9	17.2	5.6	4.8	9.7	18.0	6.0	16.0	2.8	4.0	7.8	28.5	4.5	6.6	2.7	3.2	0.0	7.2	4.5	3.9	3.2	6.0	5.4	4.3	7.2	8.2	4.8	6.2	3.9	8.2	3.1	7.6	4.1	2.8	13.9	6.4	7.0	9.2	6.1	0.1	3.7	12.2	0.0	0.0	0.1	0.0	7.9	0.4	44.7	77.2	0.0	0.0	0.0	46.5	89.3	0.0	0.0	0.1	0.0	63.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	11.5	0.0	3.9	0.0	9.1	0.0	0.0	5.6	59.5	7.6	0.0	5.0	0.0	0.0	0.0	1.9	0.0	5.0	0.0	1.6	0.1	0.0	0.0	0.1	2.1	0.4	0.0	0.4	0.0	0.4	0.1	53.5	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	14.9	2.6	9.5	9.7	18.0	7.8	28.5	7.2	6.2	7.6	6.1	6.1	0.0	0.0	40.5	0.5	5.7	0.0	0.0	1.8	4.1	33.1	11.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	13.2	0.0	0.2	3.2	6.0	0.0	5.1	13.5	0.0	51.2	3.1	0.0	6.3	0.1	0.4	42.2	0.0	0.0	6.6	0.0	0.0	1.0	9.6	12.8	8.1	1.0	5.4	1.9	0.0	12.6	0.0	91.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	100.1	16.7	0.1	10.4	0.7	4.5	0.0	0.7	0.1	0.0	0.2
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988987-104064183	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	16.9	10.9	4.2	5.2	4.9	1.5	19.5	2.6	5.1	29.6	11.2	17.6	5.8	27.4	21.6	7.5	22.3	35.8	15.4	4.8	3.7	4.3	2.7	10.2	6.0	2.9	3.1	41.6	4.5	6.6	9.6	9.4	3.1	13.3	11.4	1.0	7.7	16.0	3.2	4.1	7.7	21.8	2.8	1.6	8.4	6.8	3.7	2.2	26.3	11.5	5.8	20.8	18.9	4.4	0.3	0.6	0.7	22.2	28.3	69.3	0.5	32.0	89.4	8.3	10.5	0.4	0.2	0.9	1.8	37.5	0.4	0.1	0.4	11.9	7.0	1.6	10.0	0.6	11.2	0.2	12.7	0.9	0.5	63.2	0.7	10.0	13.8	51.9	4.4	0.6	0.4	1.3	36.5	0.3	0.8	0.5	2.7	0.1	6.7	1.0	33.6	0.2	45.5	0.4	1.3	1.7	33.5	0.8	0.4	2.4	6.0	0.5	0.7	13.2	6.2	1.3	1.9	3.9	0.8	0.3	1.0	0.7	1.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	4.9	2.6	5.1	4.8	3.7	2.9	3.1	3.1	2.8	3.7	4.4	8.0	0.0	4.6	2.9	0.3	2.8	4.2	2.4	0.0	0.8	1.0	26.3	3.9	1.5	0.1	0.0	2.1	4.1	0.4	0.0	0.0	0.1	41.2	0.6	8.3	7.5	1.8	0.0	10.2	0.0	0.8	55.9	1.1	0.4	0.0	0.1	20.7	0.3	0.6	0.0	10.5	1.3	0.0	0.6	2.8	11.5	55.9	0.4	3.6	4.7	0.6	0.5	0.0	1.0	2.6	0.3	0.0	51.9	1.2	1.4	0.0	0.0	0.1	0.5	6.6	25.2	18.0	1.1	1.1	0.2	2.4	1.4	0.6	10.7	0.0	0.1
GPC6		ENSG00000183098	"Glypican 6"	Q9Y625	13	93226807-94408020	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Excitatory neurons: 333.6;Inhibitory neurons: 496.1;Oligodendrocyte precursor cells: 691.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5;HSkMC: 70.8;hTERT-RPE1: 64.3;SuSa: 39.5;U-87 MG: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA017671	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA017671: AB_1849833"	"unprognostic (5.24e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.21e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.35e-3)"	9.1	2.2	0.8	8.9	1.9	0.1	2.2	1.7	1.5	3.6	1.1	6.3	2.3	2.4	2.4	5.2	4.1	17.0	6.2	1.3	3.1	7.7	17.7	3.5	0.4	1.7	2.4	7.3	1.6	1.8	2.9	1.3	2.3	6.2	6.5	5.6	3.1	15.1	0.6	1.1	4.3	7.8	2.0	2.2	5.4	2.0	1.9	1.7	1.7	1.9	0.9	11.6	2.4	2.1	0.0	4.7	10.2	4.5	62.5	19.5	0.0	7.2	0.0	4.9	6.4	0.0	0.0	0.2	0.0	16.0	0.0	0.0	5.7	1.2	9.1	0.0	4.1	0.0	0.1	20.2	37.8	0.1	0.1	70.8	0.5	11.7	8.1	64.3	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.1	6.4	0.0	3.4	0.0	1.6	0.1	5.5	0.0	4.1	16.8	0.0	1.9	0.0	39.5	14.0	0.0	0.0	26.9	22.6	25.4	12.3	15.9	0.1	0.0	52.8	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	1.9	1.7	1.5	1.3	3.1	1.7	2.4	2.3	2.0	1.9	2.1	0.6	0.0	0.5	163.2	0.0	0.6	0.5	0.5	0.6	50.3	0.6	1.9	1.7	4.3	0.7	7.3	10.4	0.2	0.0	0.1	0.0	0.3	6.7	1.6	25.9	1.1	0.0	0.0	333.6	0.0	0.1	31.2	0.0	3.1	0.0	36.0	5.7	41.2	0.5	0.0	496.1	0.1	2.0	1.3	1.0	5.0	4.7	0.5	1.8	31.9	0.0	2.7	0.0	691.6	13.2	0.1	0.0	1.9	0.1	1.6	0.0	14.5	0.0	115.0	0.0	34.4	20.9	4.2	2.7	0.5	0.4	0.1	0.7	11.9	0.1	0.2
GPX8	"EPLA847, UNQ847"	ENSG00000164294	"Glutathione peroxidase 8 (putative)"	Q8TED1	5	55160167-55167297	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 62.7;Extravillous trophoblasts: 218.9;Fibroblasts: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 254.4;fHDF/TERT166: 246.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036720	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA036720: AB_2675269"	"unprognostic (4.85e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (5.13e-9)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.63e-2)"	13.3	6.1	1.2	12.5	1.2	0.1	12.6	1.2	1.6	37.1	6.9	7.3	2.9	21.1	21.9	6.2	14.3	17.0	11.2	1.0	1.7	6.5	2.2	6.9	3.8	1.5	1.1	27.3	4.6	9.3	2.4	39.7	1.4	10.2	8.4	1.3	7.2	15.8	1.5	5.0	4.1	27.2	1.5	4.0	5.6	5.6	1.2	1.3	22.3	6.3	3.0	17.8	9.8	3.6	37.2	39.0	75.3	77.0	180.7	223.9	36.6	179.8	254.4	97.0	192.7	3.2	82.1	0.0	199.0	246.4	86.5	28.2	46.0	51.5	131.5	0.5	17.3	2.1	49.1	6.9	64.4	0.0	0.0	157.5	60.8	68.3	35.5	126.5	122.7	0.0	1.1	0.1	137.4	14.4	0.0	0.0	32.6	1.0	42.8	0.1	40.2	0.0	65.9	1.3	0.1	1.4	56.6	4.6	68.0	80.8	56.6	3.4	102.7	63.6	65.6	84.5	102.3	0.1	0.5	0.5	103.0	0.1	118.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	1.2	1.2	1.6	1.0	1.7	1.5	1.1	1.4	1.5	1.2	3.6	10.9	0.0	1.1	0.3	0.3	7.1	6.0	38.3	9.1	0.2	8.9	6.1	4.3	0.0	33.3	25.8	0.0	49.5	0.2	0.5	5.9	13.7	0.4	6.5	62.7	18.6	0.0	0.0	0.1	38.8	218.9	76.6	2.6	4.9	4.5	30.9	19.2	0.2	10.2	0.0	0.1	4.7	4.1	0.0	6.9	0.6	51.3	1.1	24.9	5.6	1.1	7.9	0.0	0.0	0.1	15.8	0.3	39.9	1.4	2.6	0.1	0.5	36.5	0.3	13.1	20.1	38.2	0.1	0.4	3.1	6.1	13.3	1.8	29.9	0.9	2.4
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109711780-109775428	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 929.9"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 59.0;Leydig cells: 143.5;Muller glia cells: 213.3;Peritubular cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.9"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 21.6;HHSteC: 10.3;HSkMC: 10.9"									"HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 5: Breast - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	21.7	6.4	60.3	4.6	65.3	0.5	929.9	60.4	71.1	72.5	62.9	13.9	2.3	35.1	32.9	11.6	62.0	25.8	17.0	61.4	54.5	5.5	3.9	18.0	5.0	57.2	55.4	213.9	4.7	0.2	9.4	0.8	56.7	27.9	7.8	12.4	7.9	32.6	3.9	12.2	10.3	26.5	60.1	7.7	13.2	11.4	53.5	6.4	9.1	14.0	6.5	27.9	47.6	58.6	0.0	0.0	0.0	0.0	1.7	1.6	0.4	1.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	21.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	10.3	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.6	0.0	3.9	0.9	0.7	60.3	65.3	60.4	71.1	61.4	54.5	57.2	55.4	56.7	60.1	53.5	58.6	2.5	0.0	0.5	32.3	0.0	6.6	0.9	0.2	0.0	2.0	0.5	0.8	0.9	1.5	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	9.0	0.3	12.3	2.2	0.0	2.1	0.1	0.0	0.1	59.0	1.1	0.3	0.0	0.6	5.7	0.0	0.3	0.0	0.5	0.1	0.0	0.6	9.3	15.1	143.5	0.6	10.6	1.9	0.0	213.3	0.0	2.0	0.3	0.0	0.0	127.2	0.1	0.1	0.1	0.0	0.0	6.8	26.3	2.3	9.4	2.0	1.8	1.0	6.5	0.0	2.8	2.4	0.1	0.6
HMGCLL1	"bA418P12.1, DKFZP434G1411"	ENSG00000146151	"3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1"	Q8TB92	6	55434373-55579197	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 49.9;Excitatory neurons: 80.7;Inhibitory neurons: 76.2;Oligodendrocytes: 23.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.74e-3)"		"unprognostic (1.54e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.97e-3)"		"unprognostic (2.12e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.13e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.52e-1)"	1.4	3.6	6.1	0.2	5.9	0.0	1.4	5.9	5.2	0.8	0.0	0.8	0.2	0.2	0.0	1.0	0.4	0.6	1.8	5.5	10.6	0.9	0.7	2.6	0.3	5.6	6.3	0.4	1.6	0.1	4.7	6.2	6.6	3.0	0.8	4.5	0.8	1.0	1.1	0.1	0.9	0.5	9.2	0.0	1.0	2.6	8.3	0.6	0.4	2.8	0.2	0.9	0.7	9.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.2	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.9	5.9	5.2	5.5	10.6	5.6	6.3	6.6	9.2	8.3	9.4	0.6	0.0	1.3	49.9	0.0	0.0	0.0	0.0	1.2	15.1	3.7	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.5	0.0	0.0	80.7	0.0	0.0	5.8	0.0	0.0	0.0	3.5	3.9	0.0	0.1	0.0	76.2	0.0	0.0	0.3	0.0	1.3	0.3	0.1	0.0	15.0	0.0	1.5	0.0	5.5	23.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.9	5.6	1.3	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269754-8307098	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 194.9"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 158.8;Leydig cells: 43.5;Peritubular cells: 42.9;Skeletal myocytes: 99.0;Theca cells: 25.2"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 67.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"U-2197: 182.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 10.3"	"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.34e-2)"	68.0	6.0	0.9	8.7	1.3	13.4	50.4	0.9	1.3	35.4	5.0	33.9	8.7	42.4	10.6	15.1	26.2	35.5	194.9	0.9	1.0	6.2	3.2	38.0	1.2	1.0	1.0	93.0	6.8	0.4	15.7	20.4	1.0	26.3	4.8	0.1	22.8	6.7	32.1	28.1	16.9	11.8	1.0	2.9	21.9	4.3	1.7	2.2	26.0	12.9	0.7	62.4	32.6	0.7	0.0	1.0	1.4	0.0	5.8	10.8	0.3	2.4	0.2	2.8	0.6	0.1	0.1	0.0	13.6	6.4	1.4	0.1	1.2	0.0	0.9	0.0	2.3	1.3	13.9	0.0	6.1	0.0	0.6	1.2	0.0	4.2	0.0	1.7	9.8	0.0	0.3	0.0	10.2	0.0	0.2	36.5	6.1	0.0	0.3	0.3	0.0	0.1	0.0	0.0	15.8	0.3	26.4	0.5	0.2	28.8	0.1	1.1	8.1	1.4	4.7	182.1	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.9	1.3	0.9	1.0	1.0	1.0	1.0	1.0	1.7	0.7	12.6	0.0	0.0	0.0	0.0	5.2	0.5	0.0	0.6	0.0	0.5	0.9	16.5	0.0	0.6	0.0	0.0	0.8	0.1	0.0	0.0	0.1	1.2	0.3	8.1	5.3	0.0	0.0	0.0	0.0	4.2	158.8	0.5	0.3	0.0	6.0	3.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	8.6	1.4	43.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.4	0.4	0.0	0.1	0.0	0.0	0.0	99.0	10.6	0.4	0.7	0.6	5.3	1.4	0.9	25.2	0.0	0.2
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173710-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 118.0"	"Region enriched"	"Detected in all"	5	"spinal cord: 124.7"	"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		130000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	89.3	17.5	4.4	5.5	11.8	0.0	66.9	1.7	10.4	216.2	5.4	75.1	5.7	181.4	18.9	17.1	78.7	38.6	63.3	4.6	5.2	20.9	8.2	37.7	9.9	2.8	3.2	170.9	10.1	2.1	44.6	10.2	2.8	51.4	5.2	0.3	33.6	22.9	18.5	46.7	31.3	26.3	2.3	33.0	32.5	14.9	4.5	3.3	63.4	19.7	5.3	63.5	111.9	5.0	0.0	1.5	0.1	0.0	62.7	33.5	0.2	10.2	0.1	0.0	0.0	0.0	4.0	0.0	0.6	148.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	25.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.5	5.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.4	7.6	0.1	0.1	1.1	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.8	1.7	10.4	4.6	5.2	2.8	3.2	2.8	2.3	4.5	5.0	10.3	0.0	1.3	0.7	0.1	11.7	0.1	0.2	0.0	0.1	4.8	3.9	3.9	1.5	0.7	0.0	0.0	1.3	0.8	0.0	0.0	0.2	2.4	7.2	193.5	14.0	0.0	0.0	1.9	0.2	1.4	154.5	2.0	4.2	0.0	0.0	7.5	0.0	3.8	0.0	0.2	0.0	0.0	0.0	16.2	6.1	214.9	2.6	12.4	34.7	0.0	0.2	0.0	0.5	0.7	0.8	0.0	159.9	0.0	0.1	0.0	0.1	1.5	0.5	26.3	7.0	49.8	0.7	0.7	1.3	8.8	1.0	2.6	7.0	0.0	0.2
LRRC17	"H_RG318M05.3, P37NB"	ENSG00000128606	"Leucine rich repeat containing 17"	Q8N6Y2	7	102913000-102945111	"Predicted secreted proteins"	Osteogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 76.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 31.3;Granulosa cells: 68.6;Leydig cells: 101.9;Peritubular cells: 31.6;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	94	"eosinophil: 9.9"	"Lineage enriched"	"Detected in single"	94	"granulocytes: 9.9"	"Cell line enriched"	"Detected in many"	5	"LHCN-M2: 1237.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073458			Approved	"Vesicles,Cytokinetic bridge"	"Secreted in other tissues"	Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Cytokinetic bridge"	"HPA073458: "	"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (8.57e-3)"	"unprognostic (4.48e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.30e-4)"	8.1	2.4	1.6	1.1	1.7	0.2	12.9	1.6	2.4	22.5	1.7	2.7	1.6	15.7	12.1	6.0	17.3	27.4	13.2	1.7	1.6	2.8	3.5	3.2	2.1	1.6	1.7	76.2	2.3	2.0	2.4	0.6	1.5	5.6	3.3	1.8	2.7	3.2	2.1	3.0	2.3	6.0	1.6	3.3	6.9	5.0	2.3	6.2	3.8	2.8	1.0	4.4	5.8	1.6	0.0	0.0	58.8	0.5	6.0	29.4	0.1	1.6	18.2	0.6	2.8	0.0	0.2	0.0	3.4	1.5	7.3	0.1	0.0	0.0	4.3	0.0	1.4	0.1	0.0	0.1	8.3	0.5	0.2	28.1	0.7	21.5	0.0	141.1	140.9	0.6	0.0	0.1	1237.5	0.0	0.1	0.4	3.1	0.1	0.1	0.1	244.0	0.2	0.2	0.1	1.3	1.3	0.1	0.0	0.1	0.1	0.0	1.7	11.8	0.2	1.5	15.2	2.3	1.1	0.4	0.0	0.3	0.0	0.3	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.7	1.6	2.4	1.7	1.6	1.6	1.7	1.5	1.6	2.3	1.6	3.6	0.0	1.1	4.6	0.2	0.9	0.2	0.9	0.0	3.7	0.7	0.8	1.1	0.0	0.5	1.8	2.1	0.3	0.3	0.0	0.0	1.7	3.5	2.7	15.3	4.4	0.0	0.0	6.9	0.4	0.2	31.3	1.1	4.6	1.3	68.6	6.1	0.5	0.4	0.0	8.7	0.1	2.0	0.0	2.7	2.9	101.9	0.5	5.4	10.3	0.6	0.6	0.0	2.5	5.3	0.2	0.3	31.6	0.0	0.3	0.1	0.3	0.1	2.2	65.7	16.1	17.8	0.6	0.5	0.4	0.6	0.0	0.9	6.6	0.2	0.2
LTBP4	"FLJ46318, FLJ90018, LTBP-4, LTBP-4L"	ENSG00000090006	"Latent transforming growth factor beta binding protein 4"	Q8N2S1	19	40592883-40629818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 327.1;Leydig cells: 972.3;Peritubular cells: 624.4;Skeletal myocytes: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 120.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015194	Approved				"Secreted to extracellular matrix"	NA	NA		9700000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"CAB015194: AB_2139064"	"unprognostic (3.29e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.41e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.83e-2)"	138.5	48.5	11.3	22.3	10.9	8.3	98.8	1.7	13.3	334.6	9.6	144.5	59.2	309.6	44.7	100.6	246.8	39.3	401.9	10.7	14.2	64.7	37.4	242.5	24.8	16.2	10.3	315.2	37.2	22.6	75.9	38.3	16.4	253.6	38.2	3.7	82.8	126.3	63.0	73.0	135.4	74.4	11.3	80.5	125.3	78.5	14.2	12.9	173.2	156.7	14.0	188.6	374.5	15.3	19.8	21.3	41.7	56.5	15.1	16.0	6.6	7.7	24.9	7.8	6.4	6.4	43.8	22.4	34.9	13.1	12.4	26.3	10.6	26.8	2.6	61.0	3.3	7.3	53.7	2.4	49.4	3.0	23.1	19.9	21.7	15.6	27.8	41.0	4.9	21.6	46.7	120.3	1.9	19.7	3.1	1.3	4.9	56.1	24.9	51.9	1.1	35.6	3.9	1.7	1.8	17.4	28.3	21.5	7.4	6.4	11.9	11.3	20.4	1.3	81.4	2.6	16.7	26.8	24.9	7.1	35.1	28.5	20.4	0.0	1.5	0.4	8.1	2.4	5.5	3.5	7.7	6.5	2.7	2.0	3.2	3.4	0.3	3.0	1.3	5.0	5.5	2.3	11.3	10.9	1.7	13.3	10.7	14.2	16.2	10.3	16.4	11.3	14.2	15.3	84.7	6.4	14.1	2.0	11.6	57.6	30.9	62.8	56.3	60.4	13.0	18.2	15.5	17.2	18.5	22.0	0.0	1.5	12.7	38.2	1.9	6.3	11.1	14.8	154.7	29.9	4.2	12.4	8.1	4.7	2.6	327.1	37.2	24.2	10.2	13.5	102.4	3.3	7.5	40.4	11.3	42.2	6.1	6.4	39.6	39.0	972.3	13.9	58.7	15.0	9.5	3.5	16.5	2.0	14.0	6.9	16.6	624.4	16.5	23.6	97.7	0.3	7.1	3.2	59.2	229.2	52.8	50.7	36.3	38.2	29.1	2.6	24.9	10.2	36.4	27.2
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111494	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 739.0;placenta: 535.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 966.4;Fibroblasts: 2136.1;Leydig cells: 401.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebral cortex: 5.6"	"Immune cell enriched"	"Detected in single"	122	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.1"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 1991.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"spinal cord: 149.2"	"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"	NA	NA		29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	161.5	133.5	0.6	68.1	0.7	0.3	153.2	0.6	5.6	199.8	4.2	85.0	56.1	301.0	88.3	75.7	59.2	739.0	183.8	0.7	0.9	85.0	34.6	211.4	41.3	0.9	0.8	92.9	72.9	26.3	5.3	535.9	0.8	115.2	133.0	5.7	14.3	67.4	9.6	20.0	90.6	354.5	0.7	4.8	47.1	17.5	1.3	13.4	30.8	73.0	80.3	486.0	39.2	0.8	0.0	0.3	6.9	0.0	237.4	115.9	0.7	400.8	1991.0	16.0	24.3	0.0	0.1	0.0	0.0	339.9	0.0	0.6	0.0	0.0	5.4	0.0	0.0	0.0	21.5	0.0	183.7	0.6	0.1	160.5	0.0	33.7	1.0	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.2	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.3	14.9	0.1	0.0	10.8	16.3	0.0	0.0	0.0	17.0	4.5	14.3	0.0	0.2	0.0	0.0	8.8	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6	5.6	0.7	0.9	0.9	0.8	0.8	0.7	1.3	0.8	77.5	12.8	30.9	0.0	0.6	97.6	1.2	0.8	3.4	0.2	9.4	8.6	15.2	0.0	5.0	0.0	2.1	44.9	4.0	0.1	0.0	0.7	3.5	27.0	966.4	27.2	0.0	0.0	0.0	0.0	38.9	2136.1	8.6	15.2	18.3	0.0	55.0	0.3	63.6	0.0	0.2	0.3	0.0	0.3	143.5	8.7	401.7	9.5	117.4	16.9	1.0	86.9	0.0	0.0	0.0	2.1	0.0	44.8	6.3	4.9	0.4	0.3	0.8	3.0	0.0	39.1	165.5	0.2	0.9	5.9	100.2	84.0	14.5	27.4	0.0	4.1
MATN2		ENSG00000132561	"Matrilin 2"	O00339	8	97868840-98036724	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033879	Approved				"Secreted to extracellular matrix"	NA	NA		1500000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"CAB033879: AB_2141502"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (6.65e-2)"	54.4	51.0	24.3	30.2	22.5	1.8	43.6	17.6	23.2	194.4	19.3	67.5	58.5	147.0	101.6	32.8	46.9	40.1	110.2	20.0	23.4	39.3	24.6	15.2	18.0	24.1	30.5	116.4	11.3	28.0	9.9	177.9	26.3	104.9	57.8	45.7	42.6	171.9	4.0	62.8	80.6	98.1	18.3	5.9	23.7	31.2	23.4	4.9	271.4	28.5	15.4	103.0	139.2	30.8	24.1	10.8	23.3	2.5	60.7	3.6	15.0	72.5	17.6	78.6	106.7	13.0	8.4	0.1	7.0	29.2	3.5	114.4	2.3	4.4	100.6	0.0	2.9	0.8	6.1	0.9	14.0	0.0	0.0	13.6	9.5	16.1	0.8	22.1	0.5	1.3	0.1	0.2	4.1	11.2	0.0	0.7	7.1	0.3	3.7	0.0	2.4	11.4	5.7	5.3	16.0	1.5	11.5	0.2	19.8	67.3	10.9	1.4	0.6	5.2	31.5	16.1	11.0	0.9	0.2	0.2	18.8	0.4	5.9	0.0	0.1	0.1	0.2	0.4	5.2	0.0	0.7	0.9	0.8	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	24.3	22.5	17.6	23.2	20.0	23.4	24.1	30.5	26.3	18.3	23.4	30.8	27.8	3.2	1.3	11.1	0.3	37.3	10.1	6.2	80.2	6.3	3.8	45.8	29.1	18.6	3.0	16.5	54.2	1.2	0.2	20.6	0.0	9.9	86.0	4.2	22.6	32.4	23.4	3.2	6.4	0.0	1.1	113.1	5.1	5.0	0.0	43.5	201.0	11.0	1.6	0.0	11.5	25.4	0.0	5.0	7.7	108.6	103.5	0.9	28.4	19.7	2.0	8.1	0.0	86.0	59.8	3.2	18.2	258.8	0.0	6.5	118.7	3.4	1.6	52.9	13.1	97.2	17.1	2.5	2.6	7.3	8.5	2.5	2.0	297.5	27.4	1.8
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 1062.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 222.4;Extravillous trophoblasts: 467.9;Fibroblasts: 815.9;Leydig cells: 340.2;Peritubular cells: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5619.3;ASC TERT1: 1623.2;hTERT-RPE1: 6400.4;U-87 MG: 1812.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	220000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	518.9	68.3	3.9	135.1	4.0	1.2	328.9	4.9	7.8	514.1	9.4	173.8	57.4	453.6	192.6	121.5	190.6	1062.9	212.8	3.6	5.3	43.7	15.6	279.7	28.1	7.6	4.9	271.1	42.8	13.8	14.7	225.0	5.4	116.8	171.3	11.4	124.1	137.5	60.8	455.6	177.3	468.5	6.7	58.3	134.0	49.6	8.6	19.8	113.5	66.1	30.3	660.8	238.1	10.0	6.5	3.9	192.0	2.4	5619.3	1623.2	312.7	501.4	1146.1	99.4	79.0	0.2	2.1	0.5	391.7	891.0	37.0	54.2	1.2	4.6	57.0	0.7	0.9	0.7	12.9	3.0	530.6	0.4	14.8	1396.8	1.7	512.4	4.4	6400.4	651.1	0.5	0.7	2.4	334.7	0.0	0.4	8.2	152.4	0.5	1.6	0.4	46.1	0.9	16.1	7.6	3.2	345.0	93.3	0.8	2.1	849.0	1.6	36.0	924.6	1546.0	144.9	300.5	66.9	1.0	0.6	2.2	1812.3	28.3	289.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.0	4.9	7.8	3.6	5.3	7.6	4.9	5.4	6.7	8.6	10.0	38.4	0.0	0.5	0.0	0.0	122.1	14.1	48.8	9.1	30.5	3.1	16.8	4.4	0.0	3.1	11.0	0.0	5.6	0.5	0.1	0.0	2.5	12.5	7.7	222.4	46.9	28.2	0.0	0.0	0.4	467.9	815.9	12.2	5.4	0.0	0.0	13.2	0.1	28.2	1.7	0.2	0.1	2.0	1.6	180.7	40.2	340.2	11.8	128.1	27.2	0.0	7.7	0.0	5.0	0.0	9.3	0.0	419.0	2.8	5.6	0.0	0.2	1.1	2.5	13.1	80.0	65.3	1.2	2.8	6.6	102.3	17.2	10.3	35.2	0.0	4.4
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632163-1635263	"Enzymes, Predicted intracellular proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 29.9"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 90.5;Leydig cells: 98.2;NK-cells: 64.9;Peritubular cells: 177.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 11.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.4;NTERA-2: 2.7;PC-3: 1.9;U-266/70: 3.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 7.8"	"Low region specificity"	"Detected in some"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	7.1	2.8	0.4	0.3	0.5	1.3	4.1	0.1	1.0	16.7	0.0	5.0	1.9	15.4	0.0	2.8	11.0	2.9	15.0	0.3	0.0	3.2	3.3	14.3	1.1	0.4	0.0	29.9	1.6	0.0	5.7	2.8	0.1	11.8	0.1	0.1	1.0	1.1	0.5	3.1	3.4	1.2	0.0	3.0	4.3	5.2	0.1	0.0	2.4	0.0	0.1	11.9	10.9	0.2	0.6	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.4	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.5	0.2	1.2	4.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.4	0.0	0.2	2.7	0.0	1.9	0.9	0.0	1.1	0.0	0.0	0.4	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.3	0.0	3.9	0.2	1.1	0.0	0.2	0.1	0.0	0.2	0.0	1.5	0.0	0.9	0.0	0.3	1.0	0.0	0.1	0.0	0.7	0.1	2.2	0.1	11.3	0.3	1.7	0.4	0.5	0.1	1.0	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.2	2.2	0.0	0.5	1.0	1.1	13.4	0.8	0.7	0.6	1.3	1.7	1.5	9.6	1.5	0.4	1.8	0.0	4.0	27.4	3.0	0.0	1.2	1.0	4.0	3.5	2.2	3.0	2.7	0.3	0.5	2.2	90.5	4.6	1.0	0.0	1.4	12.1	1.0	5.7	3.3	0.6	1.9	4.1	1.0	18.5	6.2	98.2	1.3	19.6	0.0	1.2	0.5	64.9	0.0	0.2	4.3	0.9	177.9	4.3	0.5	2.7	1.0	0.5	7.7	0.0	0.7	5.3	2.1	10.5	0.7	15.8	10.3	8.1	2.1	1.7	0.9
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 149.5;Extravillous trophoblasts: 259.9;Fibroblasts: 183.3;Leydig cells: 176.1;Peritubular cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"naive CD8 T-cell: 6.4"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.0;BJ: 143.6;BJ hTERT+: 66.9;fHDF/TERT166: 71.9;HSkMC: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	103.6	11.7	2.9	8.2	2.5	0.6	70.0	1.1	2.9	100.4	1.7	58.2	6.3	117.2	2.6	17.6	57.4	19.4	42.8	4.0	2.4	26.4	7.4	53.9	2.5	5.9	4.5	81.9	8.7	1.1	21.7	11.6	2.6	39.0	1.7	0.8	32.4	11.4	16.6	41.6	29.5	6.4	2.3	26.4	28.9	14.7	3.2	0.6	46.6	5.0	0.8	52.8	59.3	3.0	4.1	0.8	1.2	1.0	16.5	46.0	42.3	143.6	66.9	16.6	19.9	8.0	3.3	1.7	0.6	71.9	0.1	3.0	1.0	0.0	3.2	3.2	1.3	1.2	3.1	12.8	43.4	0.2	1.6	54.8	0.0	6.2	0.0	32.4	0.0	0.9	17.3	1.4	21.5	0.4	0.4	0.5	14.0	0.3	4.7	0.6	0.3	0.4	0.0	0.7	3.2	8.9	0.5	1.4	0.1	10.4	11.1	0.7	1.3	0.7	23.1	21.8	0.6	3.3	0.3	0.2	5.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.2	2.9	2.5	1.1	2.9	4.0	2.4	5.9	4.5	2.6	2.3	3.2	3.0	22.2	3.2	0.0	7.5	0.5	10.7	1.1	0.7	2.2	0.7	7.0	47.9	3.5	0.0	0.0	9.2	0.0	9.5	1.1	0.0	0.0	5.7	1.7	4.3	149.5	5.1	0.0	0.0	0.3	0.0	259.9	183.3	2.6	3.7	0.0	0.5	6.4	0.1	9.3	0.0	0.4	0.0	0.0	0.0	19.7	11.4	176.1	1.7	10.6	6.5	0.7	50.7	0.0	0.0	0.1	1.1	0.0	183.6	1.4	0.6	0.0	1.4	0.0	1.5	13.1	65.8	74.7	0.7	5.4	1.3	10.5	29.4	2.2	0.8	0.0	0.3
OLFML1	UNQ564	ENSG00000183801	"Olfactomedin like 1"	Q6UWY5	11	7485388-7511377	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 52.3;Leydig cells: 39.7;Peritubular cells: 39.5;Sertoli cells: 26.3;Smooth muscle cells: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 31.2;U-2197: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058824	Approved				"Secreted - unknown location"	NA	NA		260000	"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058824: "	"unprognostic (3.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (3.13e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.72e-3)"	21.6	6.2	1.4	5.2	1.8	0.3	12.5	2.2	1.9	27.2	7.5	8.4	5.0	19.0	21.3	8.2	17.5	23.8	14.8	1.8	1.9	6.4	10.8	18.9	9.3	2.0	1.5	48.6	2.8	2.3	3.1	7.3	1.7	14.1	10.2	0.2	5.6	18.3	5.2	8.3	7.2	18.0	1.2	14.7	5.4	4.1	2.1	3.2	8.2	12.1	5.6	14.9	17.7	2.0	0.0	0.0	0.4	0.0	1.9	1.9	31.2	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.2	0.1	0.1	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.2	0.1	20.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.8	0.1	0.0	0.0	1.4	1.8	2.2	1.9	1.8	1.9	2.0	1.5	1.7	1.2	2.1	2.0	6.1	0.0	0.0	1.0	0.4	5.2	0.0	0.0	1.2	0.1	0.2	0.3	1.0	0.0	0.6	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	13.3	2.9	0.0	0.0	0.1	0.0	2.0	52.3	0.0	0.4	0.0	0.0	5.0	0.9	0.6	0.0	0.1	0.0	0.0	0.0	6.1	0.7	39.7	0.4	7.2	2.8	0.0	0.0	0.0	0.5	1.4	0.1	0.0	39.5	0.2	0.1	0.0	0.3	0.0	0.0	26.3	9.4	16.3	0.3	0.1	0.2	3.7	0.3	0.7	5.0	0.0	0.1
PID1	"FLJ20701, NYGGF4"	ENSG00000153823	"Phosphotyrosine interaction domain containing 1"	Q7Z2X4	2	228850526-229271287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.0;Inhibitory neurons: 142.2;Langerhans cells: 210.4;Microglial cells: 179.9;Oligodendrocyte precursor cells: 543.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 71.1;intermediate monocyte: 79.4;myeloid DC: 83.6"	"Group enriched"	"Detected in many"	53	"dendritic cells: 83.6;monocytes: 79.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.5;hTEC/SVTERT24-B: 86.1;LHCN-M2: 57.3;REH: 62.3;RH-30: 90.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036103	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA036103: AB_10602144"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.91e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-6)"	31.2	29.5	18.8	13.9	20.8	2.9	25.8	9.0	21.2	30.2	9.0	37.6	5.5	22.9	8.9	12.0	33.9	12.7	17.0	20.6	15.5	5.6	62.2	24.4	4.4	14.8	30.5	31.0	13.8	1.5	8.8	26.1	13.6	19.2	21.5	3.8	10.2	14.8	13.1	20.0	25.1	16.7	11.8	20.3	25.5	5.5	21.4	3.4	16.6	20.8	3.6	30.9	27.0	13.8	0.0	1.9	0.0	0.0	54.5	10.5	0.1	9.2	34.7	5.8	7.1	0.7	0.0	0.0	0.2	13.0	18.0	1.7	0.0	1.7	7.8	0.0	0.0	0.0	4.0	0.1	22.3	0.0	0.1	19.8	15.5	86.1	14.0	16.1	0.0	0.0	0.0	0.1	57.3	0.1	0.1	0.0	0.9	7.6	5.2	62.3	90.7	0.1	1.1	0.0	1.8	2.3	19.4	1.8	0.1	0.7	0.2	0.0	0.0	22.3	8.3	21.1	8.8	0.1	0.0	0.0	29.3	0.1	3.7	0.0	71.1	0.0	0.0	79.4	0.4	0.2	0.0	0.2	83.6	0.0	0.0	0.0	1.5	0.0	16.7	0.4	0.3	28.4	18.8	20.8	9.0	21.2	20.6	15.5	14.8	30.5	13.6	11.8	21.4	13.8	4.0	6.4	70.9	53.8	1.6	15.6	6.1	13.5	6.8	5.7	0.9	1.7	2.6	8.6	11.1	0.0	0.0	1.9	0.2	75.7	0.0	2.5	0.1	1.4	37.8	4.1	4.9	0.4	121.0	4.0	31.5	107.3	1.1	4.4	6.3	7.8	4.2	135.0	3.3	0.0	142.2	11.9	4.1	42.5	210.4	1.9	88.0	50.1	21.4	179.9	35.2	14.0	1.0	543.4	3.5	1.6	24.2	75.2	0.5	21.9	39.5	0.3	2.5	1.3	0.0	4.8	8.7	0.4	2.1	1.4	14.5	4.8	2.4	41.0	36.0	1.4
PLAC9		ENSG00000189129	"Placenta associated 9"	Q5JTB6	10	80131682-80145359	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 124.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 926.5;Leydig cells: 873.5;Peritubular cells: 659.7;Sertoli cells: 295.9;Smooth muscle cells: 446.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.5;ASC TERT1: 85.3;BEWO: 32.1;HSkMC: 28.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 37.9"	HPA043469	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA043469: AB_10795770"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.57e-3)"	"unprognostic (5.88e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-3)"	112.3	18.4	10.2	6.6	9.2	1.2	85.7	10.3	15.5	77.3	53.3	22.1	4.0	26.9	5.0	21.4	30.4	9.0	124.3	14.3	5.9	17.9	6.4	56.1	2.7	5.9	5.8	11.5	5.7	4.1	4.9	12.5	6.4	35.9	4.6	0.6	20.1	7.6	16.9	47.8	19.7	6.5	6.5	5.0	21.4	14.9	6.9	2.2	44.6	19.2	1.9	54.0	75.7	8.5	0.2	0.0	0.8	0.0	98.5	85.3	32.1	10.3	8.7	0.9	1.2	0.0	0.7	0.0	0.2	6.0	0.1	0.8	0.1	0.0	0.0	0.8	0.3	0.0	0.5	0.0	16.4	0.0	2.3	28.7	0.0	2.1	1.2	10.6	3.4	0.4	0.0	0.4	0.0	0.3	0.1	0.6	1.9	0.4	1.5	0.0	0.1	1.5	0.0	0.6	0.0	1.8	0.0	1.2	0.7	0.2	0.1	0.2	3.6	6.6	3.6	21.0	0.2	0.7	0.9	0.1	1.9	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	10.2	9.2	10.3	15.5	14.3	5.9	5.9	5.8	6.4	6.5	6.9	8.5	246.2	3.2	1.8	0.0	1.6	126.4	0.7	1.1	8.0	0.4	7.4	14.0	24.4	0.0	0.3	0.0	0.0	7.0	3.6	0.1	0.0	0.3	4.6	3.1	75.7	102.5	1.8	0.0	0.5	0.2	17.7	926.5	5.6	4.4	1.3	0.1	115.6	0.3	14.1	0.0	0.5	0.0	0.0	0.0	191.3	26.7	873.5	7.9	136.9	7.5	0.0	50.2	0.0	0.0	0.2	0.7	0.0	659.7	2.1	1.0	0.0	0.2	0.9	1.7	295.9	89.7	446.6	2.6	2.9	4.6	126.3	11.5	14.1	1.1	0.0	1.8
PODN	"MGC24995, PCAN, PODOCAN, SLRR5A"	ENSG00000174348	Podocan	Q7Z5L7	1	53062052-53085501	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Fibroblasts: 123.5;Leydig cells: 268.7;Peritubular cells: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"gdT-cell: 5.1;memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	52	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.0;BJ: 39.2;fHDF/TERT166: 23.9;HHSteC: 94.1;U-2197: 46.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		910000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (8.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (5.91e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-2)"	191.0	14.3	9.1	13.3	8.2	0.2	116.3	6.4	8.7	106.1	7.1	76.1	11.6	105.1	19.7	36.1	127.5	103.8	87.1	6.8	8.1	5.2	12.5	66.3	3.8	7.3	10.3	178.0	20.8	2.9	19.5	18.1	8.2	69.8	8.2	0.6	48.8	34.4	20.2	45.4	26.1	44.7	6.7	3.3	75.5	26.9	10.3	10.8	71.5	30.5	2.7	101.3	87.9	6.7	0.0	0.0	0.0	0.0	23.0	3.1	0.1	39.2	5.3	0.4	0.3	0.0	0.0	0.0	0.6	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.1	0.0	0.0	14.9	0.0	0.9	0.0	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.8	9.1	8.2	6.4	8.7	6.8	8.1	7.3	10.3	8.2	6.7	10.3	6.7	8.5	0.0	3.3	0.0	0.0	6.4	0.4	0.0	0.6	0.5	0.8	0.9	1.7	1.5	0.6	0.0	0.0	0.4	1.3	0.0	0.0	0.0	1.6	0.3	11.2	3.8	0.0	0.0	0.0	0.0	0.4	123.5	2.6	0.3	0.0	0.7	4.2	0.1	0.6	0.0	1.9	0.0	0.0	0.3	8.8	9.2	268.7	1.3	5.4	6.5	0.0	0.3	3.1	5.5	0.2	0.0	0.0	261.1	1.6	0.5	0.1	0.0	0.0	0.5	0.0	4.4	16.0	0.7	0.6	0.7	6.0	0.5	1.6	0.0	0.0	0.2
PTGFR	FP	ENSG00000122420	"Prostaglandin F receptor"	P43088	1	78303884-78540701	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 20.1"	"Cell type enhanced"	"Detected in many"		"Club cells: 14.3;Fibroblasts: 22.7;Inhibitory neurons: 10.4;Langerhans cells: 10.6;Microglial cells: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"ASC TERT1: 271.2;HSkMC: 85.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (4.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.89e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.61e-2)"	"unprognostic (2.25e-1)"	"unprognostic (9.90e-2)"	"unprognostic (8.46e-4)"	"unprognostic (2.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.16e-4)"	"unprognostic (3.21e-4)"	"unprognostic (8.48e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.21e-3)"	9.9	3.4	0.6	5.7	0.4	0.0	7.2	0.1	1.8	4.6	0.3	2.0	1.0	17.9	2.4	0.9	4.6	6.9	1.7	1.9	2.7	3.9	1.3	2.5	1.2	0.7	0.5	4.6	0.9	0.0	0.2	8.1	1.8	3.1	2.7	0.2	4.7	2.0	2.1	5.2	2.4	16.7	0.4	0.6	1.6	1.4	3.5	0.1	0.8	20.1	4.3	11.9	4.4	0.2	0.0	0.0	1.0	0.0	26.5	271.2	0.0	20.5	20.0	7.0	2.7	0.0	0.0	0.0	0.0	12.4	3.8	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	85.7	0.0	1.8	17.6	18.3	0.1	0.0	0.0	0.7	10.9	0.0	0.0	0.0	0.1	0.0	15.9	0.0	0.0	0.0	2.4	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.2	5.9	8.5	4.7	2.1	1.6	1.1	0.0	0.0	0.5	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.8	1.9	2.7	0.7	0.5	1.8	0.4	3.5	0.2	1.2	0.0	8.0	0.3	0.0	6.4	0.0	1.0	0.0	1.2	0.2	0.0	0.4	5.7	14.3	9.2	0.0	0.1	0.0	0.0	3.9	4.2	8.5	0.4	0.6	0.6	0.0	0.0	0.4	0.0	0.0	22.7	0.5	0.1	0.0	0.1	0.0	2.3	0.1	0.0	10.4	0.0	0.0	0.0	10.6	9.3	5.6	0.4	5.4	17.8	0.0	0.3	0.0	0.0	0.2	0.0	1.1	0.4	0.2	0.1	0.0	0.3	6.3	0.0	6.6	7.1	1.4	1.1	0.2	0.1	4.7	0.3	0.5	0.3	0.0	0.0
RIMS4	"C20orf190, dJ781B1.3"	ENSG00000101098	"Regulating synaptic membrane exocytosis 4"	Q9H426	20	44751808-44810546	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.9"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 110.3;Horizontal cells: 38.7;Inhibitory neurons: 14.4;Sertoli cells: 26.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 6.6;glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 19.3;MCF7: 13.4;SCLC-21H: 39.9;SH-SY5Y: 20.4;SiHa: 14.0;U-2 OS: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060928	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA060928: AB_2684387"	"unprognostic (1.54e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-2)"		"unprognostic (4.63e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.60e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.94e-2)"	0.4	1.1	17.6	0.2	22.8	0.0	1.1	6.9	35.9	7.2	0.0	0.6	0.1	1.9	0.4	0.5	8.1	0.6	0.6	22.5	12.1	0.1	0.0	0.9	0.1	15.5	9.2	6.1	0.0	0.0	12.0	0.0	10.6	2.5	0.5	2.9	1.1	0.9	1.0	0.4	0.4	2.6	7.7	0.0	1.8	10.5	10.9	0.2	5.0	1.6	0.4	0.1	1.5	20.1	0.0	0.5	0.5	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.9	0.1	2.0	0.0	19.3	0.2	0.0	0.0	8.2	0.0	0.8	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	13.4	0.1	0.0	3.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	39.9	20.4	14.0	0.0	0.2	0.5	6.1	0.7	0.0	0.0	9.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	22.8	6.9	35.9	22.5	12.1	15.5	9.2	10.6	7.7	10.9	20.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	7.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.1	1.8	0.0	11.3	0.0	0.0	0.4	0.0	0.4	0.0	110.3	0.0	0.0	0.1	38.7	14.4	0.8	0.0	0.0	0.0	2.9	7.2	0.2	0.0	0.0	0.0	1.0	0.0	2.0	0.6	0.1	0.1	13.2	0.0	0.0	0.0	0.0	0.0	1.4	26.3	0.2	1.2	1.2	5.7	0.0	0.1	0.0	0.0	0.5	0.5	0.0
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780591-153789083	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 318.8;urinary bladder: 306.7"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 806.1"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"AF22: 229.1;ASC diff: 85.2;HSkMC: 140.2;NTERA-2: 318.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	188.2	16.0	4.9	84.6	4.0	0.3	154.9	3.6	6.3	23.2	11.2	72.2	18.4	12.0	22.2	212.7	62.1	318.8	6.2	12.3	13.8	4.5	0.3	62.5	11.8	4.5	3.7	8.3	45.1	7.0	72.5	0.4	4.6	56.5	44.3	2.3	83.4	70.5	6.5	80.5	57.3	89.5	3.8	0.7	34.4	1.5	2.2	9.6	92.3	38.7	3.6	306.7	63.0	12.3	0.0	0.0	229.1	0.2	85.2	15.1	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	140.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	318.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.1	0.1	0.0	8.1	0.2	0.0	0.0	0.4	0.1	0.0	12.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.0	3.6	6.3	12.3	13.8	4.5	3.7	4.6	3.8	2.2	12.3	15.5	3.2	0.6	9.4	0.5	115.5	0.8	0.0	5.7	0.0	3.7	7.9	0.3	0.0	1.9	0.0	0.0	0.1	2.0	0.0	0.0	0.2	0.0	0.1	0.1	11.8	0.0	0.0	0.7	0.0	0.2	806.1	38.7	0.3	1.3	0.0	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.0	175.0	0.5	4.1	5.0	119.2	0.0	0.6	0.0	0.0	0.5	0.1	0.1	0.0	7.2	4.1	0.7	0.0	0.1	2.9	0.0	0.0	6.7	59.4	0.0	0.1	6.9	106.0	0.1	8.6	0.0	0.0	0.9
SGCD	"CMD1L, DAGD, LGMD2F"	ENSG00000170624	"Sarcoglycan delta"	Q92629	5	155870344-156767788	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 42.9;tongue: 33.3"	"Group enriched"	"Detected in many"	4	"Astrocytes: 365.7;Cardiomyocytes: 107.8;Excitatory neurons: 193.0;Inhibitory neurons: 161.2;Microglial cells: 124.6;Oligodendrocyte precursor cells: 417.2;Oligodendrocytes: 196.4"	"Cancer enriched"	"Detected in many"	5	"melanoma: 10.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 16.1;fHDF/TERT166: 25.7;LHCN-M2: 12.7;RH-30: 18.2;SK-MEL-30: 27.0;U-138 MG: 24.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"				"unprognostic (2.23e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.37e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.66e-3)"	5.4	4.2	3.2	2.1	2.0	0.0	3.3	1.6	3.6	6.8	0.0	7.9	2.0	8.2	2.5	6.2	2.9	9.3	39.1	2.9	2.7	1.3	2.0	5.0	0.4	4.2	3.8	8.8	1.0	9.9	1.5	0.6	4.3	6.0	3.6	1.6	1.9	5.2	42.9	1.6	2.7	13.4	3.9	1.4	2.9	1.3	2.0	0.7	17.8	33.3	0.5	6.6	3.1	6.6	0.0	6.4	0.0	0.0	5.8	9.2	0.0	16.1	5.5	0.0	0.2	0.0	0.0	0.0	0.0	25.7	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.5	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	3.0	0.1	0.0	0.0	27.0	0.0	0.0	0.0	0.0	24.1	0.0	4.3	0.0	0.1	0.1	0.0	4.1	0.0	9.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.0	1.6	3.6	2.9	2.7	4.2	3.8	4.3	3.9	2.0	6.6	0.7	0.0	0.5	365.7	0.0	3.6	0.0	0.0	0.0	3.5	4.0	2.2	107.8	0.0	0.0	0.0	54.2	0.0	1.6	0.1	0.0	0.1	6.9	6.1	1.5	1.7	1.8	0.0	193.0	0.0	0.0	27.4	0.0	16.3	0.0	11.3	3.3	1.6	0.2	21.9	161.2	0.0	0.0	0.0	2.5	13.3	19.0	0.8	24.9	124.6	0.0	0.3	0.0	417.2	196.4	0.0	0.0	15.4	0.7	0.8	0.0	0.3	0.0	1.2	0.0	38.5	5.9	0.0	0.4	0.5	3.1	0.1	1.0	9.4	0.0	0.2
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421493-74533917	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Hepatocytes: 63.7;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 83.9;GAMG: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA072719: AB_2686552"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (3.16e-4)"	13.8	24.7	4.6	4.8	5.8	0.0	5.4	1.7	5.7	9.4	1.2	7.0	3.3	10.3	1.7	2.9	9.3	6.0	10.4	7.7	4.9	7.9	40.7	7.5	0.9	5.6	3.9	12.8	5.5	11.7	9.8	9.2	1.8	6.2	1.8	1.1	5.0	5.8	2.7	2.5	3.1	6.9	3.5	1.2	4.7	0.9	8.1	5.7	12.6	3.7	1.8	6.6	6.2	3.0	8.4	10.4	7.2	43.1	20.8	11.1	0.0	83.9	29.7	38.2	20.6	0.1	0.9	0.0	1.3	37.5	70.8	1.7	1.1	40.2	22.1	6.1	3.6	0.0	0.0	0.0	1.5	0.0	0.0	16.5	9.5	19.3	23.3	14.6	0.1	0.1	0.0	0.0	9.1	0.0	0.5	2.7	27.2	0.0	7.8	17.4	19.9	0.0	18.0	0.1	1.9	12.0	9.6	50.2	0.3	2.5	0.6	1.1	0.0	32.5	8.8	35.7	41.9	0.0	0.0	0.0	34.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.8	1.7	5.7	7.7	4.9	5.6	3.9	1.8	3.5	8.1	3.0	5.6	0.0	0.6	22.2	0.2	0.8	4.3	2.4	0.6	5.7	4.3	3.4	4.5	8.6	2.9	3.7	0.0	5.7	0.1	0.0	3.9	4.3	0.1	0.3	9.8	6.1	8.4	0.0	14.5	2.4	4.9	11.8	0.5	0.5	2.5	1.7	3.6	63.7	1.0	3.3	21.6	0.3	0.0	1.3	0.8	1.2	15.2	0.1	3.6	15.9	0.6	6.2	0.0	23.1	7.1	4.6	0.0	20.7	0.1	5.1	0.4	4.7	2.4	1.5	13.1	9.7	5.6	0.1	0.1	0.9	1.3	2.1	0.4	1.4	0.2	4.9
SLC1A7	EAAT5	ENSG00000162383	"Solute carrier family 1 member 7"	O00341	1	53087179-53142638	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 40.2"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 207.7;Cone photoreceptor cells: 70.9;Rod photoreceptor cells: 72.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Cell line enriched"	"Detected in some"	8	"HHSteC: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049124	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA049124: AB_2680643"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.48e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.26e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.70e-3)"	1.6	0.2	1.5	0.2	1.0	0.0	1.1	1.0	1.5	1.4	0.8	1.0	2.3	1.3	0.0	1.2	1.8	5.2	1.6	1.2	1.1	0.4	1.0	0.6	0.1	1.6	1.9	2.4	0.2	0.4	0.1	0.2	1.8	0.8	0.0	40.2	0.5	0.0	1.3	0.8	3.1	0.0	1.5	0.0	0.8	0.5	2.3	0.0	0.6	3.0	0.0	1.0	1.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	1.5	1.0	1.0	1.5	1.2	1.1	1.6	1.9	1.8	1.5	2.3	1.2	1.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	207.7	0.0	0.0	0.6	0.0	0.0	0.0	70.9	0.1	3.0	2.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.2	5.9	4.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	1.0	0.0	0.3	0.0	0.0	1.2	0.5	0.0	7.5	0.0	8.5	16.5	0.0	0.1	0.0	4.0	1.2	0.7	0.0	17.7	0.7	0.0	72.3	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	1.7	0.1	0.3	0.0
SLIT2	"SLIL3, Slit-2"	ENSG00000145147	"Slit guidance ligand 2"	O94813	4	20251905-20620561	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Excitatory neurons: 256.7;Inhibitory neurons: 544.9;Oligodendrocytes: 157.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 98.0;BJ hTERT+: 200.8;BJ hTERT+ SV40 Large T+: 97.8;fHDF/TERT166: 117.8;HBF TERT88: 112.0;HEK 293: 88.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007590, HPA019511, HPA023088"	Uncertain				"Secreted in other tissues"	NA	NA		77000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB007590: , HPA019511: AB_1857226, HPA023088: AB_1857227"	"unprognostic (1.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.01e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.32e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (4.93e-3)"	"unprognostic (6.80e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.16e-4)"	8.0	24.9	3.2	3.3	6.4	0.0	9.4	0.0	14.0	24.0	11.7	11.5	2.4	16.4	9.9	5.8	13.1	9.4	7.8	6.6	20.5	12.3	2.0	34.9	1.8	7.9	3.1	4.3	2.8	1.5	8.8	25.2	4.5	12.6	5.4	13.2	6.1	15.7	2.9	3.8	4.8	24.9	0.4	14.2	9.0	1.3	17.6	2.4	9.2	5.1	1.2	13.1	13.9	2.4	0.1	0.0	54.6	0.0	37.8	34.8	1.7	98.0	200.8	97.8	36.9	0.4	0.1	0.0	3.4	117.8	0.2	1.2	15.7	7.9	112.0	0.2	88.3	0.0	0.4	0.0	7.2	0.9	0.0	8.5	0.0	63.6	18.6	2.1	35.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	1.7	0.0	6.3	61.2	0.5	0.0	1.0	0.1	3.5	0.8	0.0	0.2	0.4	1.9	0.2	0.2	2.0	34.9	5.0	35.0	54.2	0.0	0.1	0.0	0.9	0.0	19.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	6.4	0.0	14.0	6.6	20.5	7.9	3.1	4.5	0.4	17.6	2.4	1.6	0.0	9.0	10.1	0.0	8.0	2.0	0.1	0.6	47.6	1.0	0.6	5.2	1.5	1.3	0.0	0.0	1.1	0.0	0.6	1.9	1.7	0.6	6.4	1.9	2.0	1.2	0.0	256.7	0.5	1.2	58.8	0.0	7.1	2.5	1.3	4.2	0.2	1.9	0.0	544.9	0.0	0.0	1.0	9.7	1.7	26.4	0.7	8.8	31.9	0.0	1.3	0.0	43.7	157.9	0.2	0.0	26.7	0.1	3.7	0.0	11.5	7.4	2.1	6.6	3.2	6.4	0.2	1.7	1.2	6.7	2.1	1.1	20.3	0.1	1.9
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 107.1;Bipolar cells: 70.3;Excitatory neurons: 41.4;Muller glia cells: 33.0;Oligodendrocytes: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 7.6;HaCaT: 19.6;HMC-1: 14.5;RPMI-8226: 9.1;SiHa: 14.1;THP-1: 8.4;U-937: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071818			Approved	Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA071818: "	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	2.4	1.1	13.4	3.4	18.3	1.7	1.6	11.6	15.9	8.5	0.0	4.5	1.4	4.7	3.8	2.2	3.3	3.6	2.0	12.1	11.3	9.0	4.6	4.4	0.8	18.6	17.6	5.8	0.7	0.0	2.7	0.2	14.7	5.2	1.1	12.9	1.0	2.4	1.1	1.8	2.6	6.2	11.3	0.4	1.6	1.6	14.1	3.1	3.1	1.2	1.2	3.0	3.7	22.9	0.8	1.1	1.3	0.2	0.1	0.0	0.0	0.2	0.1	1.6	0.4	0.2	0.6	0.0	7.6	5.0	1.3	19.6	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.3	0.2	0.0	14.5	0.2	4.3	6.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.4	0.0	0.9	0.0	1.6	9.1	0.2	0.0	0.8	0.7	14.1	0.0	0.0	0.8	0.0	8.4	0.0	4.9	1.4	0.0	0.1	0.0	0.0	0.0	1.6	8.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	18.3	11.6	15.9	12.1	11.3	18.6	17.6	14.7	11.3	14.1	22.9	0.1	3.2	11.3	107.1	0.0	0.1	0.3	4.6	0.0	70.3	0.1	2.4	2.0	0.0	6.9	5.5	0.0	0.0	0.3	0.0	0.0	0.2	2.2	0.4	0.4	0.3	0.0	0.0	41.4	0.0	0.0	5.0	0.0	0.9	0.0	5.4	0.4	1.6	0.2	1.7	24.3	0.0	2.0	0.3	0.0	11.6	12.8	0.4	1.8	8.4	0.1	33.0	1.0	8.0	76.2	1.1	0.0	7.9	0.1	0.4	0.4	1.4	2.0	2.7	0.0	0.9	1.0	0.1	0.3	0.0	0.4	0.0	0.3	1.5	0.0	0.6
TCEAL5	WEX4	ENSG00000204065	"Transcription elongation factor A like 5"	Q5H9L2	X	103273691-103276750	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 67.3;choroid plexus: 35.5;pituitary gland: 62.2;retina: 23.5;testis: 60.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.4;Granulosa cells: 16.5;Late spermatids: 22.1;Muller glia cells: 75.5;Peritubular cells: 35.7"	"Cancer enhanced"	"Detected in many"		"glioma: 13.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 9.0;SH-SY5Y: 28.0"	"Low region specificity"	"Detected in all"							"HPA045564, HPA058982"	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (1.30e-3)"	"unprognostic (2.41e-1)"		"prognostic unfavorable (9.09e-4)"	"unprognostic (9.68e-2)"	"unprognostic (8.75e-4)"		"unprognostic (1.21e-1)"		"unprognostic (8.11e-2)"	"prognostic favorable (8.60e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.03e-4)"	0.9	10.5	56.5	0.9	54.9	0.0	2.1	55.4	67.3	6.2	35.5	2.2	0.6	5.6	6.8	0.3	2.4	0.8	2.7	52.9	55.2	0.3	0.1	0.3	0.0	50.8	52.6	5.2	0.9	0.0	62.2	0.0	49.5	3.3	0.7	23.5	1.1	4.1	0.1	0.4	1.2	3.3	44.9	0.0	1.0	60.0	50.3	0.6	2.3	0.7	0.0	1.5	3.8	55.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.5	54.9	55.4	67.3	52.9	55.2	50.8	52.6	49.5	44.9	50.3	55.4	0.1	0.0	0.0	2.9	0.0	0.1	0.5	0.0	1.8	43.4	0.3	9.5	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.3	7.5	0.6	0.0	0.0	7.0	0.0	0.4	7.6	0.0	0.2	0.0	16.5	0.0	0.0	0.3	1.7	7.7	0.0	0.0	0.0	1.7	22.1	8.4	0.7	0.0	2.8	0.0	75.5	0.0	7.1	2.8	0.0	0.0	35.7	0.0	0.2	0.0	0.3	0.0	6.8	0.0	6.9	1.4	7.6	1.9	0.1	0.3	0.4	0.1	0.2	0.0	0.2
TCF21	"bHLHa23, POD1"	ENSG00000118526	"Transcription factor 21"	O43680	6	133889113-133895553	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 100.4;ovary: 88.3;placenta: 137.2"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 123.8;Leydig cells: 102.2;Peritubular cells: 116.9;Sertoli cells: 118.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.7;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HHSteC: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013189	Uncertain					NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"HPA013189: AB_10601215"	"unprognostic (2.43e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-1)"		"unprognostic (8.60e-2)"	"unprognostic (4.78e-5)"	"unprognostic (2.58e-2)"		"unprognostic (6.66e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.95e-1)"	8.9	10.7	0.1	11.0	0.0	0.0	0.3	0.4	1.7	3.3	2.7	24.6	23.4	9.4	13.1	19.4	3.5	20.2	22.6	1.6	0.0	38.3	5.1	58.5	0.3	0.2	0.0	88.3	10.4	1.3	3.5	137.2	0.1	37.0	21.2	0.0	0.1	42.2	1.1	0.1	26.7	14.3	0.0	100.4	21.0	3.4	0.1	0.1	0.3	0.7	0.0	40.3	8.5	0.1	0.0	1.3	0.0	0.2	0.2	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	51.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.0	2.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.7	1.6	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	5.5	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.6	1.3	0.0	0.0	0.0	0.0	1.9	123.8	0.5	0.0	0.0	0.5	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	102.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.9	0.1	0.3	0.0	0.0	0.0	0.0	118.3	0.3	20.8	0.3	0.4	1.4	0.0	5.7	0.1	14.5	0.0	0.4
TMEM100	"FLJ10970, FLJ37856"	ENSG00000166292	"Transmembrane protein 100"	Q9NV29	17	55719627-55732121	"Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 192.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 57.8;Endothelial cells: 25.5;Fibroblasts: 40.7;Leydig cells: 40.7;Peritubular cells: 52.6;Sertoli cells: 32.9"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 28.9;ASC TERT1: 19.5;HHSteC: 44.8;HSkMC: 20.6;U-87 MG: 13.9;WM-115: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055936	Approved		Uncertain	Nucleoplasm		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA055936: AB_2682975"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.07e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (5.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (4.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.26e-3)"	40.8	5.0	5.4	3.2	5.5	0.0	27.6	4.3	9.0	15.8	6.0	14.5	6.7	3.6	36.6	6.5	8.0	7.3	18.7	5.1	7.0	1.9	7.0	192.5	1.2	5.5	7.0	26.5	2.3	0.8	11.2	54.1	6.0	10.3	11.6	0.4	8.0	24.7	9.7	4.6	13.2	5.5	4.6	6.9	30.2	2.7	8.1	1.1	7.5	14.1	0.6	11.1	8.2	4.7	0.0	0.0	5.9	0.0	28.9	19.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	44.8	0.0	0.0	20.6	0.0	1.4	0.1	0.2	0.0	0.3	1.0	0.1	0.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	8.7	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	1.9	3.9	0.0	0.8	0.0	0.1	13.9	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.5	4.3	9.0	5.1	7.0	5.5	7.0	6.0	4.6	8.1	4.7	57.8	0.0	3.6	2.3	0.1	2.5	0.3	0.0	1.2	0.7	0.4	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	4.0	25.5	0.0	0.0	0.1	0.0	0.0	40.7	1.5	0.2	1.3	0.1	7.1	15.2	0.1	0.0	1.6	0.0	0.0	0.0	4.9	0.5	40.7	0.2	7.2	1.9	0.0	0.0	0.0	17.1	0.0	0.1	0.0	52.6	0.0	0.1	0.0	3.4	0.0	0.1	32.9	10.3	15.1	0.1	0.2	0.7	2.6	0.1	0.5	0.3	0.0	0.3
TRHDE	"PAP-II, PGPEP2, TRH-DE"	ENSG00000072657	"Thyrotropin releasing hormone degrading enzyme"	Q9UKU6	12	72087266-72670758	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.6;pancreas: 10.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 216.9;Inhibitory neurons: 292.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.9;cerebellum: 4.4;cerebral cortex: 2.5;hippocampal formation: 7.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 30.3;BJ hTERT+: 29.1;EFO-21: 15.3;HBF TERT88: 10.3;hTERT-RPE1: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		7300000		"Cluster 22: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.56e-2)"	"unprognostic (4.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.44e-6)"	"unprognostic (1.77e-1)"	"unprognostic (6.37e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.14e-4)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.53e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.94e-2)"	3.6	0.9	0.1	0.3	4.9	0.4	0.8	4.4	2.5	3.7	0.0	1.1	2.4	1.2	0.6	0.2	1.1	0.8	0.8	7.6	0.0	5.1	0.5	1.4	0.1	0.0	0.9	3.2	10.3	0.0	0.1	0.1	0.0	1.3	0.5	0.8	0.8	2.8	0.2	0.2	2.1	0.4	0.0	2.5	0.3	0.7	0.0	0.1	0.0	0.4	0.3	1.2	2.3	0.0	3.6	0.0	0.6	0.0	1.6	0.0	9.5	30.3	29.1	2.9	1.9	0.0	0.0	0.0	15.3	4.3	3.0	0.4	5.4	0.0	10.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	2.3	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.7	0.0	0.0	0.0	9.5	6.7	2.9	0.1	0.0	0.0	0.0	0.5	0.0	5.7	0.0	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	4.4	2.5	7.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.5	2.9	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.9	1.5	0.0	1.8	0.0	0.1	0.0	7.1	3.9	0.0	35.9	0.1	0.4	0.2	0.0	0.0	216.9	2.6	0.4	4.7	0.0	0.3	0.0	0.1	0.4	1.4	0.2	0.0	292.7	3.5	0.0	0.0	0.0	62.8	29.5	0.7	0.0	2.8	0.0	0.4	0.0	38.2	4.0	2.2	3.9	13.5	0.0	0.2	15.8	9.1	0.7	0.6	0.0	37.4	0.6	0.2	0.7	0.0	0.0	0.1	0.1	0.2	1.6	0.1
VSTM4	"C10orf72, FLJ31737"	ENSG00000165633	"V-set and transmembrane domain containing 4"	Q8IW00	10	49014236-49115522	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Granulosa cells: 96.9;Late spermatids: 140.6;Sertoli cells: 59.2;Theca cells: 44.7"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 22.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 8.6;RH-30: 9.3;SH-SY5Y: 7.9;U-138 MG: 10.6;U-2197: 24.0;U-87 MG: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017279	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA017279: AB_10959519"	"unprognostic (8.46e-2)"	"unprognostic (5.41e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.25e-4)"	18.7	41.5	7.1	3.2	9.0	0.3	9.8	8.0	6.6	22.3	7.7	7.8	2.5	12.3	7.4	7.8	8.5	10.5	12.3	6.2	7.6	12.3	3.9	10.9	3.5	8.9	9.3	35.2	1.5	26.8	5.1	10.4	9.2	13.5	5.6	2.3	3.4	11.7	5.6	4.9	4.9	11.4	8.6	2.3	5.6	9.4	8.4	6.5	27.8	5.9	4.6	12.0	7.5	9.4	0.0	0.0	3.1	0.1	1.3	0.7	0.1	2.6	4.1	0.9	0.2	0.0	0.1	0.1	0.1	6.1	3.4	0.1	0.2	0.0	0.4	3.2	1.4	0.2	0.1	0.1	0.1	0.1	0.0	4.7	0.0	4.2	0.0	0.0	0.0	0.8	8.6	0.1	0.8	0.1	0.0	0.2	0.6	0.0	0.0	0.0	9.3	5.0	0.0	0.1	0.1	7.9	0.1	0.0	0.0	0.4	0.1	0.3	0.0	10.6	1.2	24.0	0.1	0.0	6.8	0.0	11.6	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.3	0.1	0.1	0.0	0.0	7.1	9.0	8.0	6.6	6.2	7.6	8.9	9.3	9.2	8.6	8.4	9.4	9.4	3.2	17.5	17.3	1.3	6.5	1.6	0.1	0.6	5.4	1.2	1.1	16.7	0.0	9.4	0.0	2.1	0.4	3.7	0.2	1.9	0.1	88.5	0.8	10.7	6.2	0.0	0.0	11.1	0.0	0.3	29.7	0.0	0.7	12.6	96.9	5.3	5.0	0.7	5.0	7.0	0.0	0.0	2.2	11.1	140.6	9.6	2.9	7.2	4.7	1.0	9.1	2.1	20.1	33.3	0.2	0.1	14.7	0.7	0.8	0.0	9.4	3.8	2.9	59.2	20.6	37.7	1.3	4.4	0.4	4.3	0.4	2.0	44.7	0.0	0.7